| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.905 | 0.002 | 0.986 | DNA synthesis inhibitor | 0.737 0.004 DBMET00412 0.516 0.012 DBMET03666 0.959 0.001 DBMET03664 0.51 0.013 DB02377 0.986 0.001 DBMET03665 0.416 0.02 DBMET00499 0.279 0.051 DBMET00498 0.25 0.066 DB11100 | DBMET03665 | |
| 0.862 | 0.001 | 0.862 | Adenosine A2 receptor antagonist | 0.367 0.004 DBMET00412 0.402 0.004 DBMET03666 0.225 0.009 DBMET03664 0.251 0.007 DB02377 0.113 0.024 DBMET03665 0.319 0.005 DBMET00499 0.068 0.041 DBMET00498 | ||
| 0.858 | 0.001 | 0.858 | DNA repair enzyme inhibitor | 0.255 0.005 DBMET00412 0.513 0.002 DBMET03666 0.804 0.001 DBMET03664 0.259 0.005 DB02377 0.511 0.002 DBMET03665 0.237 0.006 DBMET00499 0.199 0.009 DBMET00498 | ||
| 0.846 | 0.001 | 0.846 | Adenosine A2a receptor antagonist | 0.345 0.004 DBMET00412 0.364 0.004 DBMET03666 0.193 0.01 DBMET03664 0.196 0.01 DB02377 0.109 0.023 DBMET03665 0.248 0.007 DBMET00499 0.065 0.04 DBMET00498 | ||
| 0.816 | 0.001 | 0.816 | Adenosine deaminase inhibitor | 0.324 0.001 DBMET00412 0.126 0.004 DBMET03666 0.432 0.001 DBMET03664 0.128 0.003 DB02377 0.49 0.001 DBMET03665 0.085 0.008 DBMET00499 0.061 0.02 DBMET00498 | ||
| 0.796 | 0.002 | 0.796 | Adenosine A1 receptor antagonist | 0.54 0.003 DBMET00412 0.274 0.007 DBMET03666 0.375 0.005 DBMET03664 0.342 0.005 DB02377 0.196 0.011 DBMET03665 0.354 0.005 DBMET00499 0.112 0.021 DBMET00498 | ||
| 0.772 | 0.002 | 0.959 | RNA-directed DNA polymerase inhibitor | 0.643 0.004 DBMET00412 0.513 0.01 DBMET03666 0.911 0.001 DBMET03664 0.533 0.009 DB02377 0.959 0.001 DBMET03665 0.473 0.012 DBMET00499 0.337 0.026 DBMET00498 0.331 0.026 DB11100 | DBMET03665 | |
| 0.764 | 0.004 | 0.764 | Vasodilator, coronary | 0.464 0.021 DBMET00412 0.238 0.146 DBMET03666 0.474 0.019 DBMET03664 0.208 0.175 DB02377 0.66 0.005 DBMET03665 0.235 0.149 DBMET00499 | ||
| 0.717 | 0.003 | 0.717 | DNA methylase inhibitor | 0.271 0.038 DBMET00412 0.214 0.07 DBMET03666 0.545 0.005 DBMET03664 0.418 0.01 DBMET03665 | ||
| 0.712 | 0.001 | 0.839 | NADH dehydrogenase inhibitor | 0.49 0.003 DBMET00412 0.287 0.007 DBMET03666 0.814 0 DBMET03664 0.257 0.008 DB02377 0.839 0 DBMET03665 0.456 0.004 DBMET00499 0.223 0.009 DBMET00498 0.118 0.03 DB11100 | DBMET03665 | |
| 0.694 | 0.007 | 0.786 | Vasodilator, peripheral | 0.341 0.078 DBMET00412 0.617 0.014 DBMET03664 0.786 0.004 DBMET03665 | DBMET03665 | |
| 0.679 | 0 | 0.907 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.444 0.001 DBMET00412 0.198 0.007 DBMET03666 0.849 0 DBMET03664 0.202 0.007 DB02377 0.907 0 DBMET03665 0.182 0.007 DBMET00499 0.136 0.009 DBMET00498 0.064 0.031 DB11100 | DBMET03665 | |
| 0.658 | 0.007 | 0.658 | Immunomodulator | 0.197 0.168 DBMET00412 0.526 0.02 DBMET03666 0.638 0.008 DBMET03664 0.26 0.107 DB02377 0.642 0.008 DBMET03665 0.192 0.174 DBMET00499 0.439 0.034 DBMET00498 | ||
| 0.651 | 0.002 | 0.686 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.495 0.004 DBMET00412 0.202 0.07 DBMET03666 0.665 0.001 DBMET03664 0.168 0.111 DB02377 0.686 0.001 DBMET03665 0.222 0.057 DBMET00499 0.244 0.045 DBMET00498 | DBMET03665 | |
| 0.645 | 0.002 | 0.645 | Adenosine A3 receptor antagonist | 0.42 0.004 DBMET00412 0.299 0.005 DBMET03666 0.212 0.009 DBMET03664 0.197 0.009 DB02377 0.201 0.009 DBMET03665 0.348 0.004 DBMET00499 0.148 0.013 DBMET00498 | ||
| 0.63 | 0.003 | 0.804 | Adenylate cyclase inhibitor | 0.343 0.01 DBMET00412 0.148 0.046 DBMET03666 0.747 0.001 DBMET03664 0.232 0.021 DB02377 0.804 0.001 DBMET03665 0.346 0.01 DBMET00499 | DBMET03665 | |
| 0.63 | 0.004 | 0.734 | Cyclic AMP phosphodiesterase inhibitor | 0.578 0.004 DBMET00412 0.234 0.072 DBMET03666 0.454 0.01 DBMET03664 0.334 0.03 DB02377 0.271 0.054 DBMET03665 0.734 0.003 DBMET00499 0.291 0.045 DBMET00498 | DBMET00499 | |
| 0.601 | 0.002 | 0.916 | Antimetabolite | 0.322 0.005 DBMET00412 0.221 0.009 DBMET03666 0.863 0.001 DBMET03664 0.201 0.009 DB02377 0.916 0.001 DBMET03665 0.191 0.01 DBMET00499 0.168 0.011 DBMET00498 0.05 0.031 DB11100 | DBMET03665 | |
| 0.581 | 0.002 | 0.927 | Phosphofructokinase-1 inhibitor | 0.269 0.007 DBMET00412 0.09 0.036 DBMET03666 0.876 0 DBMET03664 0.126 0.023 DB02377 0.927 0 DBMET03665 0.142 0.02 DBMET00499 0.083 0.039 DBMET00498 0.074 0.045 DB11100 | DBMET03665 | |
| 0.569 | 0.003 | 0.939 | Glutamate dehydrogenase inhibitor | 0.154 0.015 DBMET00412 0.113 0.025 DBMET03666 0.906 0 DBMET03664 0.165 0.013 DB02377 0.939 0 DBMET03665 0.139 0.018 DBMET00499 0.081 0.043 DBMET00498 0.097 0.032 DB11100 | DBMET03665 | |
| 0.547 | 0.002 | 0.78 | Carbamoyl phosphate synthetase inhibitor | 0.235 0.006 DBMET00412 0.107 0.018 DBMET03666 0.732 0 DBMET03664 0.146 0.012 DB02377 0.78 0 DBMET03665 0.199 0.007 DBMET00499 0.109 0.018 DBMET00498 0.132 0.014 DB11100 | DBMET03665 | |
| 0.54 | 0.002 | 0.953 | Fumarate hydratase inhibitor | 0.061 0.01 DBMET00412 0.038 0.02 DBMET03666 0.921 0 DBMET03664 0.049 0.014 DB02377 0.953 0 DBMET03665 0.058 0.011 DBMET00499 0.033 0.026 DB11100 | DBMET03665 | |
| 0.536 | 0.001 | 0.76 | Phosphoglycerate kinase inhibitor | 0.171 0.004 DBMET00412 0.092 0.007 DBMET03666 0.571 0 DBMET03664 0.046 0.016 DB02377 0.76 0 DBMET03665 0.033 0.027 DBMET00499 | DBMET03665 | |
| 0.538 | 0.005 | 0.797 | Cytidine deaminase inhibitor | 0.502 0.006 DBMET00412 0.674 0.003 DBMET03664 0.797 0.002 DBMET03665 0.155 0.072 DBMET00499 0.194 0.05 DBMET00498 | DBMET03665 | |
| 0.531 | 0.004 | 0.745 | DNA polymerase I inhibitor | 0.564 0.003 DBMET00412 0.354 0.008 DBMET03666 0.621 0.002 DBMET03664 0.603 0.003 DB02377 0.745 0.001 DBMET03665 0.444 0.005 DBMET00499 0.17 0.039 DBMET00498 | DBMET03665 | |
| 0.54 | 0.024 | 0.735 | Immunostimulant | 0.446 0.038 DBMET00412 0.17 0.139 DBMET03666 0.735 0.006 DBMET03664 0.188 0.128 DB02377 0.713 0.007 DBMET03665 0.159 0.147 DBMET00499 0.32 0.073 DBMET00498 | DBMET03664 | |
| 0.514 | 0.004 | 0.514 | DNA methyltransferase I inhibitor | 0.179 0.08 DBMET00412 | ||
| 0.453 | 0.002 | 0.96 | Thymidine kinase inhibitor | 0.673 0.001 DBMET00412 0.103 0.006 DBMET03666 0.887 0.001 DBMET03664 0.232 0.002 DB02377 0.96 0 DBMET03665 0.189 0.003 DBMET00499 0.098 0.006 DBMET00498 0.037 0.035 DB11100 | DBMET03665 | |
| 0.459 | 0.012 | 0.497 | Interleukin agonist | 0.291 0.052 DBMET00412 0.164 0.154 DBMET03666 0.497 0.009 DBMET03664 0.218 0.104 DB02377 0.364 0.025 DBMET03665 | DBMET03664 | |
| 0.489 | 0.044 | 0.568 | Antibacterial | 0.379 0.086 DBMET00412 0.568 0.025 DBMET03664 0.518 0.036 DBMET03665 | DBMET03664 | |
| 0.472 | 0.041 | 0.624 | Immunosuppressant | 0.624 0.01 DBMET00412 0.269 0.135 DBMET03666 0.599 0.013 DBMET03664 0.327 0.099 DB02377 0.533 0.024 DBMET03665 | DBMET00412 | |
| 0.433 | 0.002 | 0.594 | Adenylate kinase inhibitor | 0.304 0.007 DBMET00412 0.111 0.052 DBMET03666 0.549 0.001 DBMET03664 0.159 0.023 DB02377 0.594 0.001 DBMET03665 0.163 0.022 DBMET00499 0.122 0.042 DBMET00498 0.144 0.029 DB11100 | DBMET03665 | |
| 0.433 | 0.004 | 0.638 | UDP-glucose 4-epimerase inhibitor | 0.399 0.006 DBMET00412 0.591 0.001 DBMET03664 0.093 0.069 DB02377 0.638 0.001 DBMET03665 0.196 0.019 DBMET00499 0.116 0.046 DBMET00498 0.143 0.031 DB11100 | DBMET03665 | |
| 0.426 | 0.002 | 0.943 | Argininosuccinate synthase inhibitor | 0.215 0.007 DBMET00412 0.118 0.016 DBMET03666 0.897 0 DBMET03664 0.186 0.009 DB02377 0.943 0 DBMET03665 0.2 0.008 DBMET00499 0.064 0.034 DBMET00498 0.077 0.026 DB11100 | DBMET03665 | |
| 0.42 | 0.007 | 0.478 | Alkylator | 0.185 0.031 DBMET00412 0.171 0.037 DBMET03666 0.478 0.005 DBMET03664 0.149 0.047 DB02377 0.368 0.009 DBMET03665 0.128 0.061 DBMET00499 | DBMET03664 | |
| 0.408 | 0.002 | 0.408 | Adenosine A1 receptor agonist | 0.151 0.003 DBMET00412 0.102 0.004 DBMET03664 0.071 0.004 DBMET03665 | ||
| 0.411 | 0.027 | 0.411 | Hypoxia-inducible factor 1 alpha inhibitor | 0.291 0.07 DBMET00412 0.337 0.049 DBMET03666 0.215 0.134 DB02377 0.188 0.167 DBMET00499 | ||
| 0.374 | 0.003 | 0.374 | Adenosine A2b receptor antagonist | 0.064 0.021 DBMET00412 0.273 0.004 DBMET03666 0.068 0.019 DBMET03664 0.123 0.008 DB02377 0.332 0.003 DBMET00499 0.045 0.04 DBMET00498 | ||
| 0.371 | 0.004 | 0.632 | Aminoacyl-tRNA synthetase inhibitor | 0.257 0.008 DBMET00412 0.102 0.043 DBMET03666 0.452 0.003 DBMET03664 0.632 0.002 DBMET03665 | DBMET03665 | |
| 0.392 | 0.03 | 0.392 | DNA damaging | 0.329 0.047 DBMET03664 0.269 0.071 DBMET03665 | ||
| 0.356 | 0.006 | 0.822 | Hexokinase inhibitor | 0.182 0.047 DBMET00412 0.692 0.002 DBMET03664 0.822 0.001 DBMET03665 0.123 0.114 DBMET00499 | DBMET03665 | |
| 0.353 | 0.003 | 0.641 | Biliverdin reductase inhibitor | 0.169 0.008 DBMET00412 0.066 0.035 DBMET03666 0.641 0 DBMET03664 0.114 0.015 DB02377 0.641 0 DBMET03665 0.232 0.004 DBMET00499 0.129 0.012 DBMET00498 0.112 0.015 DB11100 | DBMET03665 | |
| 0.35 | 0.004 | 0.941 | Ornithine carbamoyltransferase inhibitor | 0.111 0.014 DBMET00412 0.07 0.026 DBMET03666 0.886 0.001 DBMET03664 0.099 0.016 DB02377 0.941 0 DBMET03665 0.1 0.016 DBMET00499 0.047 0.043 DBMET00498 0.073 0.024 DB11100 | DBMET03665 | |
| 0.324 | 0.001 | 0.496 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.384 0.001 DBMET00412 0.052 0.004 DBMET03666 0.496 0.001 DBMET03664 0.097 0.002 DB02377 0.232 0.001 DBMET03665 0.078 0.003 DBMET00499 0.047 0.004 DBMET00498 | DBMET03664 | |
| 0.305 | 0.023 | 0.305 | Peptidyltransferase inhibitor | 0.299 0.025 DBMET00412 0.292 0.027 DBMET03664 0.267 0.04 DBMET03665 0.26 0.044 DBMET00499 0.24 0.058 DB11100 | ||
| 0.28 | 0.002 | 0.494 | Adenosine kinase inhibitor | 0.095 0.003 DBMET00412 0.312 0.001 DBMET03664 0.494 0.001 DBMET03665 | DBMET03665 | |
| 0.313 | 0.044 | 0.572 | Vasodilator | 0.256 0.066 DBMET00412 0.407 0.022 DBMET03664 0.467 0.014 DBMET03665 0.572 0.007 DBMET00499 | DBMET00499 | |
| 0.266 | 0.006 | 0.654 | Phosphodiesterase I inhibitor | 0.117 0.029 DBMET00412 0.195 0.011 DBMET03666 0.476 0.003 DBMET03664 0.225 0.008 DB02377 0.654 0.002 DBMET03665 0.308 0.005 DBMET00499 0.12 0.027 DBMET00498 0.131 0.022 DB11100 | DBMET03665 | |
| 0.246 | 0.003 | 0.337 | Acyl-CoA dehydrogenase inhibitor | 0.147 0.009 DBMET00412 0.051 0.042 DBMET03666 0.321 0.001 DBMET03664 0.095 0.018 DB02377 0.337 0.001 DBMET03665 0.081 0.022 DBMET00499 0.049 0.043 DBMET00498 | DBMET03665 | |
| 0.24 | 0.002 | 0.24 | Adenosine A3 receptor agonist | 0.112 0.003 DBMET00412 0.031 0.005 DBMET03664 0.017 0.013 DB02377 0.026 0.006 DBMET03665 | ||
| 0.239 | 0.001 | 0.564 | AICAR transformylase inhibitor | 0.185 0.002 DBMET00412 0.148 0.003 DBMET03666 0.564 0 DBMET03664 0.171 0.002 DB02377 0.329 0.001 DBMET03665 0.147 0.003 DBMET00499 0.072 0.009 DBMET00498 | DBMET03664 | |
| 0.313 | 0.077 | 0.313 | Apoptosis antagonist | 0.26 0.117 DBMET00412 0.233 0.144 DBMET03664 | ||
| 0.236 | 0.001 | 0.236 | Adenosine A2 receptor agonist | 0.056 0.003 DBMET00412 0.02 0.008 DBMET03666 0.042 0.004 DBMET03664 0.02 0.008 DBMET03665 | ||
| 0.256 | 0.025 | 0.256 | Protein kinase stimulant | 0.227 0.033 DBMET03664 | ||
| 0.229 | 0.003 | 0.496 | Purinergic P2X1 antagonist | 0.157 0.006 DBMET00412 0.058 0.046 DBMET03666 0.412 0.001 DBMET03664 0.06 0.043 DB02377 0.496 0.001 DBMET03665 0.083 0.023 DBMET00499 0.143 0.008 DBMET00498 | DBMET03665 | |
| 0.214 | 0.003 | 0.558 | Inosine monophosphate dehydrogenase inhibitor | 0.097 0.005 DBMET00412 0.558 0.001 DBMET03664 0.544 0.001 DBMET03665 0.053 0.013 DBMET00498 | DBMET03664 | |
| 0.214 | 0.005 | 0.699 | Heat shock protein 70 antagonist | 0.143 0.065 DBMET00412 0.38 0.003 DBMET03664 0.699 0.001 DBMET03665 | DBMET03665 | |
| 0.288 | 0.082 | 0.307 | Interleukin 2 agonist | 0.307 0.069 DBMET00412 0.202 0.186 DBMET03664 | DBMET00412 | |
| 0.207 | 0.008 | 0.753 | CDK1/cyclin B1 inhibitor | 0.753 0.002 DBMET03666 0.406 0.004 DB02377 0.093 0.031 DBMET00499 0.062 0.058 DBMET00498 | DBMET03666 | |
| 0.209 | 0.013 | 0.541 | DNA directed RNA polymerase inhibitor | 0.133 0.03 DBMET00412 0.128 0.032 DBMET03666 0.336 0.006 DBMET03664 0.149 0.024 DB02377 0.541 0.004 DBMET03665 0.168 0.019 DBMET00499 0.095 0.063 DBMET00498 | DBMET03665 | |
| 0.193 | 0.002 | 0.193 | Adenosine A2b receptor agonist | 0.035 0.003 DBMET00412 0.023 0.004 DBMET03664 0.02 0.005 DBMET03665 | ||
| 0.191 | 0.005 | 0.302 | Purinergic P2X2 antagonist | 0.076 0.042 DBMET00412 0.15 0.011 DBMET03666 0.243 0.003 DBMET03664 0.058 0.053 DB02377 0.302 0.002 DBMET03665 | DBMET03665 | |
| 0.21 | 0.024 | 0.21 | Topoisomerase I inhibitor | 0.173 0.034 DBMET00412 0.154 0.04 DBMET03664 0.097 0.072 DBMET03665 | ||
| 0.285 | 0.103 | 0.285 | Transcription factor NF kappa B inhibitor | |||
| 0.191 | 0.009 | 0.35 | Death-associated protein kinase 1 inhibitor | 0.35 0.003 DBMET03666 0.152 0.036 DB02377 0.143 0.052 DBMET00498 | DBMET03666 | |
| 0.182 | 0.001 | 0.766 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.169 0.001 DBMET00412 0.115 0.002 DBMET03666 0.442 0 DBMET03664 0.168 0.001 DB02377 0.766 0 DBMET03665 0.133 0.001 DBMET00499 0.07 0.006 DBMET00498 0.029 0.018 DB11100 | DBMET03665 | |
| 0.193 | 0.024 | 0.3 | Cyclin-dependent kinase 9 inhibitor | 0.3 0.009 DBMET03666 0.129 0.041 DB02377 | DBMET03666 | |
| 0.239 | 0.075 | 0.239 | Angiogenesis stimulant | 0.162 0.115 DBMET00412 0.21 0.089 DBMET03664 | ||
| 0.193 | 0.029 | 0.686 | Aldehyde dehydrogenase inhibitor | 0.613 0.004 DBMET03664 0.686 0.003 DBMET03665 | DBMET03665 | |
| 0.166 | 0.003 | 0.166 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.032 0.004 DBMET00412 0.02 0.006 DBMET03664 0.018 0.008 DBMET03665 | ||
| 0.19 | 0.028 | 0.291 | MAP kinase 3 inhibitor | 0.266 0.006 DBMET03666 0.148 0.071 DBMET03664 0.291 0.005 DB02377 0.176 0.037 DBMET00499 | DB02377 | |
| 0.183 | 0.023 | 0.197 | Adenylate cyclase stimulant | 0.167 0.039 DBMET00412 0.197 0.015 DBMET03664 0.124 0.115 DB02377 0.158 0.05 DBMET03665 0.144 0.073 DBMET00499 0.128 0.105 DBMET00498 | DBMET03664 | |
| 0.22 | 0.061 | 0.22 | Platelet adhesion inhibitor | 0.161 0.095 DBMET03664 0.145 0.112 DBMET03665 | ||
| 0.314 | 0.163 | 0.37 | Apoptosis agonist | 0.37 0.128 DBMET03664 0.258 0.205 DBMET03665 | DBMET03664 | |
| 0.264 | 0.115 | 0.264 | Cholesterol antagonist | |||
| 0.183 | 0.034 | 0.215 | CF transmembrane conductance regulator agonist | 0.215 0.015 DBMET03666 0.199 0.022 DB02377 0.171 0.046 DBMET00499 | DBMET03666 | |
| 0.149 | 0.001 | 0.149 | Adenosine A2a receptor agonist | 0.039 0.004 DBMET00412 0.019 0.008 DBMET03666 0.041 0.004 DBMET03664 0.023 0.007 DBMET03665 | ||
| 0.329 | 0.189 | 0.329 | Antiinflammatory | 0.275 0.24 DBMET03666 | ||
| 0.141 | 0.004 | 0.141 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.087 0.026 DBMET00412 0.092 0.02 DBMET03666 0.07 0.061 DBMET03664 0.106 0.01 DB02377 0.078 0.04 DBMET00499 | ||
| 0.136 | 0.001 | 0.823 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.049 0.002 DBMET00412 0.823 0 DBMET03666 0.031 0.003 DBMET03664 0.695 0.001 DB02377 0.028 0.004 DBMET03665 0.062 0.001 DBMET00499 0.037 0.002 DBMET00498 | DBMET03666 | |
| 0.152 | 0.02 | 0.261 | Alcohol dehydrogenase inhibitor | 0.259 0.007 DBMET03664 0.092 0.062 DB02377 0.261 0.007 DBMET03665 0.13 0.029 DBMET00499 | DBMET03665 | |
| 0.163 | 0.031 | 0.344 | Expectorant | 0.188 0.023 DBMET03664 0.344 0.006 DBMET03665 | DBMET03665 | |
| 0.124 | 0.001 | 0.702 | Purine nucleoside phosphorylase inhibitor | 0.073 0.002 DBMET00412 0.058 0.002 DBMET03666 0.627 0 DBMET03664 0.254 0.001 DB02377 0.702 0 DBMET03665 0.035 0.002 DBMET00499 0.021 0.003 DBMET00498 | DBMET03665 | |
| 0.133 | 0.014 | 0.381 | Ribonucleotide reductase inhibitor | 0.084 0.025 DBMET00412 0.272 0.005 DBMET03664 0.381 0.003 DBMET03665 | DBMET03665 | |
| 0.121 | 0.003 | 0.375 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.02 0.013 DBMET00412 0.375 0.001 DBMET03664 0.367 0.001 DBMET03665 | DBMET03664 | |
| 0.131 | 0.016 | 0.727 | CDK1/cyclin B inhibitor | 0.727 0.003 DBMET03666 0.552 0.004 DB02377 0.094 0.027 DBMET00499 | DBMET03666 | |
| 0.123 | 0.016 | 0.123 | Interferon agonist | 0.121 0.017 DBMET03666 0.106 0.024 DBMET03664 0.101 0.028 DB02377 0.112 0.021 DBMET00498 | ||
| 0.183 | 0.077 | 0.183 | Hepatoprotectant | 0.148 0.112 DBMET00412 0.134 0.129 DBMET03664 0.141 0.119 DBMET03665 | ||
| 0.106 | 0.003 | 0.178 | Thymidine phosphorylase inhibitor | 0.168 0.002 DBMET00412 0.178 0.002 DBMET03664 0.033 0.01 DB02377 0.096 0.003 DBMET03665 0.11 0.003 DBMET00499 0.157 0.002 DBMET00498 0.049 0.005 DB11100 | DBMET03664 | |
| 0.11 | 0.008 | 0.453 | Purinergic P2Y antagonist | 0.335 0.003 DBMET03664 0.453 0.002 DBMET03665 0.052 0.025 DBMET00499 0.088 0.011 DBMET00498 | DBMET03665 | |
| 0.13 | 0.032 | 0.307 | Folate antagonist | 0.234 0.006 DBMET03666 0.265 0.004 DBMET03664 0.307 0.003 DB02377 0.226 0.007 DBMET03665 | DB02377 | |
| 0.296 | 0.198 | 0.607 | Caspase 9 stimulant | 0.607 0.035 DBMET03664 0.326 0.167 DBMET03665 | DBMET03664 | |
| 0.121 | 0.025 | 0.164 | Transcription factor NF kappa B stimulant | 0.098 0.041 DBMET00412 0.132 0.02 DBMET03664 0.164 0.013 DBMET03665 | DBMET03665 | |
| 0.106 | 0.01 | 0.106 | Interferon inducer | 0.103 0.011 DBMET03666 0.082 0.022 DB02377 0.096 0.014 DBMET00498 | ||
| 0.134 | 0.039 | 0.175 | Transcription factor STAT6 inhibitor | 0.175 0.011 DBMET03664 0.12 0.06 DBMET03665 | DBMET03664 | |
| 0.169 | 0.074 | 0.575 | Phospholipase C inhibitor | 0.575 0.004 DBMET03664 0.288 0.019 DBMET03665 | DBMET03664 | |
| 0.111 | 0.017 | 0.111 | T cell inhibitor | 0.079 0.07 DBMET03666 0.096 0.028 DB02377 | ||
| 0.151 | 0.058 | 0.232 | Cyclin-dependent kinase 7 inhibitor | 0.232 0.024 DBMET03666 | DBMET03666 | |
| 0.103 | 0.013 | 0.746 | Phosphorylase inhibitor | 0.043 0.035 DBMET00412 0.514 0.002 DBMET03664 0.746 0.002 DBMET03665 | DBMET03665 | |
| 0.104 | 0.018 | 0.174 | Ribonucleoside-diphosphate reductase inhibitor | 0.07 0.029 DBMET00412 0.173 0.009 DBMET03664 0.174 0.008 DBMET03665 | DBMET03665 | |
| 0.228 | 0.146 | 0.451 | Antithrombotic | 0.451 0.038 DBMET03664 0.346 0.066 DBMET03665 | DBMET03664 | |
| 0.222 | 0.141 | 0.222 | Caspase 3 stimulant | |||
| 0.086 | 0.006 | 0.42 | Thymidylate synthase inhibitor | 0.102 0.004 DBMET00412 0.068 0.013 DBMET03666 0.42 0.001 DBMET03664 0.121 0.004 DB02377 0.259 0.002 DBMET03665 0.075 0.009 DBMET00499 0.081 0.007 DBMET00498 | DBMET03664 | |
| 0.119 | 0.039 | 0.545 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.135 0.032 DBMET00412 0.545 0.002 DBMET03664 0.544 0.002 DBMET03665 0.099 0.055 DBMET00499 0.134 0.032 DB11100 | DBMET03664 | |
| 0.111 | 0.035 | 0.111 | Phosphodiesterase 6D inhibitor | 0.102 0.047 DBMET00412 0.088 0.083 DBMET03664 0.1 0.053 DBMET00499 | ||
| 0.126 | 0.052 | 0.637 | Cyclin-dependent kinase 1 inhibitor | 0.526 0.005 DBMET03666 0.637 0.004 DB02377 0.308 0.011 DBMET00499 | DB02377 | |
| 0.073 | 0.002 | 0.073 | Purinergic P2Y15 antagonist | 0.044 0.005 DBMET00412 0.033 0.013 DBMET03666 0.035 0.01 DBMET03664 0.037 0.008 DB02377 0.033 0.012 DBMET00499 0.028 0.02 DBMET00498 | ||
| 0.076 | 0.005 | 0.354 | Purinergic P2X agonist | 0.056 0.008 DBMET00412 0.16 0.002 DBMET03664 0.354 0.001 DBMET03665 | DBMET03665 | |
| 0.135 | 0.065 | 0.203 | Alpha-N-acetylglucosaminidase inhibitor | 0.179 0.041 DBMET00412 0.103 0.098 DB02377 0.133 0.066 DBMET00499 0.203 0.033 DBMET00498 0.159 0.05 DB11100 | DBMET00498 | |
| 0.074 | 0.004 | 0.099 | Guanylate cyclase inhibitor | 0.091 0.001 DBMET03664 0.099 0.001 DBMET03665 | DBMET03665 | |
| 0.076 | 0.006 | 0.718 | HCV NS5B polymerase inhibitor | 0.389 0.003 DBMET03664 0.718 0.001 DBMET03665 | DBMET03665 | |
| 0.108 | 0.04 | 0.108 | Thioredoxin inhibitor | 0.089 0.064 DBMET00412 0.084 0.074 DBMET03664 | ||
| 0.121 | 0.053 | 0.262 | Mucolytic | 0.161 0.027 DBMET03664 0.262 0.005 DBMET03665 | DBMET03665 | |
| 0.085 | 0.018 | 0.085 | Protein 50S ribosomal subunit inhibitor | 0.064 0.028 DBMET00412 0.084 0.018 DBMET03664 0.073 0.022 DBMET03665 | ||
| 0.231 | 0.166 | 0.556 | Toll-Like receptor agonist | 0.462 0.04 DBMET03666 0.427 0.05 DB02377 0.556 0.023 DBMET00499 | DBMET00499 | |
| 0.065 | 0.002 | 0.17 | Purinergic P2Y1 agonist | 0.022 0.005 DBMET00412 0.14 0.001 DBMET03664 0.17 0 DBMET03665 | DBMET03665 | |
| 0.173 | 0.112 | 0.581 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.581 0.007 DBMET03666 0.26 0.063 DB02377 0.215 0.084 DBMET00499 | DBMET03666 | |
| 0.115 | 0.054 | 0.148 | AMP-activated protein kinase stimulant | 0.129 0.042 DBMET00412 0.113 0.055 DBMET03664 0.148 0.029 DBMET00498 | DBMET00498 | |
| 0.063 | 0.004 | 0.168 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.037 0.007 DBMET00412 0.135 0.002 DBMET03664 0.168 0.002 DBMET03665 | DBMET03665 | |
| 0.1 | 0.045 | 0.103 | Histamine N-methyltransferase inhibitor | 0.086 0.06 DBMET03666 0.103 0.043 DB02377 0.077 0.07 DBMET00499 | DB02377 | |
| 0.078 | 0.023 | 0.675 | Cyclin B1 inhibitor | 0.539 0.003 DBMET03666 0.675 0.003 DB02377 0.274 0.004 DBMET00499 | DB02377 | |
| 0.181 | 0.126 | 0.345 | Nitric-oxide synthase stimulant | 0.297 0.012 DBMET03666 0.345 0.005 DB02377 0.277 0.018 DBMET00499 0.206 0.079 DBMET00498 | DB02377 | |
| 0.085 | 0.034 | 0.086 | Phosphodiesterase VI inhibitor | 0.086 0.033 DBMET00499 | DBMET00499 | |
| 0.07 | 0.021 | 0.65 | Cyclin B2 inhibitor | 0.498 0.003 DBMET03666 0.65 0.003 DB02377 0.25 0.004 DBMET00499 | DB02377 | |
| 0.126 | 0.077 | 0.126 | Amylase inhibitor | |||
| 0.051 | 0.002 | 0.066 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.046 0.003 DBMET00412 0.04 0.003 DBMET03666 0.022 0.01 DBMET03664 0.033 0.004 DB02377 0.066 0.002 DBMET00499 0.034 0.004 DBMET00498 | DBMET00499 | |
| 0.072 | 0.025 | 0.126 | Corticotropin releasing factor 2 receptor antagonist | 0.095 0.008 DBMET03666 0.089 0.011 DBMET03664 0.126 0.004 DBMET03665 0.076 0.021 DBMET00499 | DBMET03665 | |
| 0.091 | 0.045 | 0.178 | mTOR complex 2 inhibitor | 0.178 0.006 DBMET03666 0.151 0.009 DB02377 0.09 0.047 DBMET00499 | DBMET03666 | |
| 0.054 | 0.011 | 0.054 | Antibiotic Aminoglycoside-like | 0.05 0.013 DBMET00412 0.046 0.016 DBMET03664 0.043 0.019 DBMET03665 | ||
| 0.13 | 0.086 | 0.157 | Cell wall synthesis inhibitor | 0.157 0.059 DBMET03664 0.13 0.086 DBMET03665 0.117 0.103 DBMET00499 0.123 0.095 DB11100 | DBMET03664 | |
| 0.045 | 0.003 | 0.045 | Isoleucine-tRNA ligase inhibitor | |||
| 0.066 | 0.025 | 0.598 | Cyclin B inhibitor | 0.48 0.003 DBMET03666 0.598 0.003 DB02377 0.231 0.004 DBMET00499 | DB02377 | |
| 0.043 | 0.004 | 0.465 | Purinergic receptor agonist | 0.039 0.004 DBMET00412 0.109 0.001 DBMET03664 0.465 0.001 DBMET03665 | DBMET03665 | |
| 0.043 | 0.004 | 0.465 | Purinergic P2 agonist | 0.039 0.004 DBMET00412 0.109 0.001 DBMET03664 0.465 0.001 DBMET03665 | DBMET03665 | |
| 0.159 | 0.12 | 0.194 | MAP kinase kinase 5 inhibitor | 0.194 0.039 DBMET03666 0.161 0.112 DB02377 | DBMET03666 | |
| 0.14 | 0.105 | 0.14 | Nitric oxide antagonist | |||
| 0.036 | 0.004 | 0.452 | Purinergic P2Y agonist | 0.033 0.004 DBMET00412 0.1 0.001 DBMET03664 0.452 0.001 DBMET03665 | DBMET03665 | |
| 0.043 | 0.014 | 0.207 | Purinergic P2Y2 antagonist | 0.036 0.02 DBMET00412 0.151 0.003 DBMET03664 0.207 0.002 DBMET03665 | DBMET03665 | |
| 0.031 | 0.002 | 0.047 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET00412 0.043 0.001 DBMET03664 0.019 0.012 DB02377 0.047 0.001 DBMET03665 0.017 0.015 DBMET00499 | DBMET03665 | |
| 0.039 | 0.011 | 0.34 | Purinergic P2T antagonist | 0.098 0.005 DBMET03664 0.34 0.003 DBMET03665 | DBMET03665 | |
| 0.067 | 0.042 | 0.382 | Purinergic P2 antagonist | 0.282 0.005 DBMET03664 0.382 0.004 DBMET03665 0.055 0.053 DBMET00499 0.214 0.006 DBMET00498 | DBMET03665 | |
| 0.093 | 0.068 | 0.556 | Xanthine oxidase inhibitor | 0.194 0.021 DBMET03666 0.271 0.01 DB02377 0.306 0.007 DBMET00499 0.556 0.003 DBMET00498 | DBMET00498 | |
| 0.09 | 0.067 | 0.647 | CDK2/cyclin A inhibitor | 0.647 0.004 DBMET03666 0.269 0.008 DB02377 0.115 0.046 DBMET00499 | DBMET03666 | |
| 0.034 | 0.011 | 0.672 | Purinergic P2Y12 antagonist | 0.095 0.004 DBMET03664 0.277 0.003 DBMET03665 0.055 0.006 DBMET00499 0.672 0.002 DBMET00498 | DBMET00498 | |
| 0.077 | 0.055 | 0.113 | MAP kinase kinase 7 inhibitor | 0.113 0.005 DBMET03666 0.108 0.008 DB02377 0.085 0.034 DBMET00499 0.081 0.044 DBMET00498 | DBMET03666 | |
| 0.057 | 0.036 | 0.074 | Adenine nucleotide translocase inhibitor | 0.056 0.037 DBMET00412 0.074 0.012 DBMET03664 0.066 0.019 DBMET03665 | DBMET03664 | |
| 0.02 | 0.002 | 0.106 | Purinergic P2Y2 agonist | 0.018 0.002 DBMET00412 0.048 0.001 DBMET03664 0.01 0.008 DB02377 0.106 0 DBMET03665 | DBMET03665 | |
| 0.037 | 0.02 | 0.727 | RNA-directed RNA polymerase inhibitor | 0.315 0.003 DBMET03664 0.727 0.001 DBMET03665 | DBMET03665 | |
| 0.032 | 0.016 | 0.103 | Uridine phosphorylase inhibitor | 0.063 0.005 DBMET00412 0.103 0.002 DBMET03664 0.067 0.004 DBMET03665 0.033 0.015 DBMET00499 0.056 0.006 DBMET00498 0.04 0.012 DB11100 | DBMET03664 | |
| 0.067 | 0.052 | 0.37 | HIV-1 reverse transcriptase inhibitor | 0.147 0.015 DBMET03664 0.37 0.004 DBMET03665 0.118 0.023 DBMET00498 | DBMET03665 | |
| 0.055 | 0.04 | 0.394 | Phosphodiesterase II inhibitor | 0.071 0.023 DBMET03666 0.072 0.022 DB02377 0.117 0.008 DBMET00499 0.394 0.002 DBMET00498 | DBMET00498 | |
| 0.148 | 0.137 | 0.576 | Dyrk kinase inhibitor | 0.576 0.008 DBMET03666 0.253 0.07 DB02377 0.214 0.091 DBMET00499 | DBMET03666 | |
| 0.027 | 0.016 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET00412 | DBMET00412 | |
| 0.06 | 0.05 | 0.066 | Selectin antagonist | 0.066 0.045 DBMET00412 | DBMET00412 | |
| 0.048 | 0.038 | 0.385 | Phosphodiesterase 2A inhibitor | 0.062 0.023 DBMET03666 0.058 0.025 DB02377 0.096 0.009 DBMET00499 0.385 0.002 DBMET00498 | DBMET00498 | |
| 0.074 | 0.066 | 0.487 | Phosphodiesterase 3A inhibitor | 0.145 0.017 DBMET03666 0.134 0.019 DB02377 0.185 0.01 DBMET00499 0.487 0.003 DBMET00498 | DBMET00498 | |
| 0.077 | 0.07 | 0.084 | Thioredoxin reductase inhibitor | 0.084 0.052 DBMET03665 | DBMET03665 | |
| 0.017 | 0.01 | 0.105 | Purinergic P2Y1 antagonist | 0.085 0.003 DBMET03664 0.105 0.003 DBMET03665 | DBMET03665 | |
| 0.05 | 0.044 | 0.056 | Alpha-mannosidase inhibitor | 0.056 0.033 DBMET00412 | DBMET00412 | |
| 0.155 | 0.151 | 0.155 | Tumour necrosis factor alpha release inhibitor | |||
| 0.218 | 0.214 | 0.844 | DNA directed DNA polymerase inhibitor | 0.288 0.168 DBMET00412 0.588 0.058 DBMET03664 0.359 0.134 DB02377 0.844 0.013 DBMET03665 0.328 0.149 DBMET00499 0.5 0.082 DBMET00498 | DBMET03665 | |
| 0.082 | 0.079 | 0.318 | Uric acid excretion stimulant | 0.098 0.054 DBMET00412 0.222 0.01 DBMET00499 0.318 0.005 DBMET00498 | DBMET00498 | |
| 0.024 | 0.022 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.013 DBMET00412 | DBMET00412 | |
| 0.201 | 0.199 | 0.566 | Toll-Like receptor 7 agonist | 0.439 0.046 DBMET03666 0.409 0.056 DB02377 0.566 0.021 DBMET00499 | DBMET00499 | |
| 0.041 | 0.039 | 0.051 | Mannosidase inhibitor | 0.051 0.025 DBMET00412 | DBMET00412 | |
| 0.045 | 0.044 | 0.045 | Cytokine production stimulant | |||
| 0.003 | 0.002 | 0.038 | Purinergic P2Y6 agonist | 0.003 0.002 DBMET00412 0.016 0 DBMET03664 0.038 0 DBMET03665 | DBMET03665 | |
| 0.003 | 0.004 | 0.165 | Purinergic P2Y4 agonist | 0.004 0.003 DBMET00412 0.015 0.001 DBMET03664 0.165 0 DBMET03665 | DBMET03665 | |
| 0.006 | 0.008 | 0.062 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.01 0.004 DBMET03666 0.011 0.003 DBMET03664 0.062 0.002 DB02377 0.009 0.004 DBMET03665 0.007 0.006 DBMET00498 | DB02377 | |
| 0.084 | 0.088 | 0.112 | Interleukin 12 antagonist | 0.112 0.037 DB02377 | DB02377 | |
| 0.005 | 0.01 | 0.035 | DNA polymerase III subunit alpha inhibitor | 0.01 0.003 DBMET00412 0.011 0.003 DBMET03666 0.013 0.003 DB02377 0.018 0.002 DBMET00499 0.035 0.001 DBMET00498 | DBMET00498 | |
| 0.07 | 0.081 | 0.521 | CDK/cyclin complex inhibitor | 0.521 0.005 DBMET03666 0.338 0.008 DB02377 | DBMET03666 | |
| 0.078 | 0.092 | 0.311 | Phosphodiesterase 7B inhibitor | 0.205 0.01 DBMET03666 0.116 0.041 DBMET03664 0.269 0.005 DB02377 0.089 0.072 DBMET03665 0.311 0.004 DBMET00499 | DBMET00499 | |
| 0.075 | 0.089 | 0.117 | Hematopoietic | 0.085 0.059 DBMET00412 0.114 0.025 DBMET03664 0.117 0.024 DB02377 0.086 0.057 DBMET03665 | DB02377 | |
| 0.014 | 0.032 | 0.023 | Tryptophan hydroxylase 1 inhibitor | 0.023 0.004 DBMET03666 0.017 0.012 DB02377 | DBMET03666 | |
| 0.025 | 0.047 | 0.058 | Purinergic P2X3 antagonist | 0.034 0.025 DB02377 0.058 0.008 DBMET03665 | DBMET03665 | |
| 0.139 | 0.161 | 0.196 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.196 0.093 DB02377 0.177 0.111 DB11100 | DB02377 | |
| 0.109 | 0.132 | 0.209 | Insulin secretagoues | 0.155 0.07 DBMET00412 0.139 0.086 DBMET03664 0.209 0.032 DBMET03665 | DBMET03665 | |
| 0.121 | 0.146 | 0.156 | MAP kinase kinase 4 inhibitor | 0.156 0.051 DBMET03666 0.141 0.081 DB02377 | DBMET03666 | |
| 0.105 | 0.131 | 0.17 | Acetylcholine M1 receptor antagonist | 0.17 0.058 DBMET03665 | DBMET03665 | |
| 0.036 | 0.066 | 0.096 | Glucose-6-phosphate isomerase inhibitor | 0.096 0.005 DBMET03664 0.062 0.017 DBMET03665 0.044 0.04 DBMET00498 | DBMET03664 | |
| 0.054 | 0.084 | 0.299 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.245 0.006 DBMET03664 0.299 0.004 DBMET03665 | DBMET03665 | |
| 0.022 | 0.055 | 0.091 | DNA polymerase III inhibitor | 0.032 0.011 DBMET00412 0.038 0.006 DBMET03666 0.029 0.018 DBMET03664 0.045 0.004 DB02377 0.035 0.008 DBMET03665 0.062 0.003 DBMET00499 0.091 0.002 DBMET00498 | DBMET00498 | |
| 0.132 | 0.166 | 0.295 | Platelet antagonist | 0.209 0.095 DBMET03664 0.295 0.054 DBMET03665 | DBMET03665 | |
| 0.034 | 0.068 | 0.574 | Purinergic P2X4 antagonist | 0.299 0.003 DBMET03664 0.574 0.002 DBMET03665 | DBMET03665 | |
| 0.028 | 0.064 | 0.973 | Phosphodiesterase 3B inhibitor | 0.117 0.008 DBMET03666 0.127 0.007 DB02377 0.266 0.004 DBMET00499 0.973 0.001 DBMET00498 | DBMET00498 | |
| 0.046 | 0.088 | 0.211 | Cyclin B3 inhibitor | 0.211 0.005 DBMET03666 0.189 0.007 DB02377 | DBMET03666 | |
| 0.105 | 0.148 | 0.149 | MAP3K9 inhibitor | 0.14 0.075 DBMET03666 0.134 0.086 DB02377 0.149 0.061 DBMET00499 | DBMET00499 | |
| 0.031 | 0.075 | 0.295 | Xanthine dehydrogenase inhibitor | 0.115 0.012 DBMET03666 0.12 0.011 DB02377 0.154 0.007 DBMET00499 0.295 0.003 DBMET00498 | DBMET00498 | |
| 0.024 | 0.084 | 0.36 | Nicotinic acid receptor 1 agonist | 0.36 0.002 DBMET00412 0.043 0.026 DBMET03666 0.149 0.005 DB02377 0.207 0.004 DBMET00499 | DBMET00412 | |
| 0.049 | 0.11 | 0.203 | Protein kinase B gamma inhibitor | 0.144 0.018 DBMET03666 0.076 0.051 DBMET00499 0.203 0.008 DBMET00498 | DBMET00498 | |
| 0.086 | 0.148 | 0.374 | CDC-like kinase 1 inhibitor | 0.374 0.005 DBMET03666 0.131 0.085 DB02377 | DBMET03666 | |
| 0.054 | 0.12 | 0.114 | ErbB-3 antagonist | 0.114 0.033 DBMET03666 | DBMET03666 | |
| 0.019 | 0.086 | 0.167 | Dihydropteroate synthase inhibitor | 0.159 0.003 DBMET03666 0.167 0.003 DB02377 0.059 0.012 DBMET00498 | DB02377 | |
| 0.034 | 0.101 | 0.25 | Cyclin A2 inhibitor | 0.25 0.007 DBMET03666 0.176 0.011 DB02377 0.065 0.043 DBMET00499 | DBMET03666 | |
| 0.03 | 0.099 | 0.114 | CDK9/cyclin T1 inhibitor | 0.114 0.015 DBMET03666 | DBMET03666 | |
| 0.072 | 0.145 | 0.154 | mTOR complex 1 inhibitor | 0.154 0.01 DBMET03666 0.134 0.017 DB02377 0.12 0.029 DBMET00499 | DBMET03666 | |
| 0.032 | 0.104 | 0.113 | Factor IXa inhibitor | 0.059 0.027 DBMET03666 0.113 0.007 DB02377 | DB02377 | |
| 0.049 | 0.122 | 0.14 | Protein kinase A inhibitor | 0.111 0.039 DBMET03666 0.14 0.027 DB02377 0.077 0.063 DBMET00499 | DB02377 | |
| 0.034 | 0.11 | 0.079 | Cyclin H inhibitor | 0.079 0.02 DBMET03666 0.072 0.026 DB02377 | DBMET03666 | |
| 0.082 | 0.159 | 0.565 | Interleukin 4 antagonist | 0.565 0.004 DBMET00498 | DBMET00498 | |
| 0.018 | 0.1 | 0.042 | Toll-Like receptor 4 agonist | 0.042 0.004 DBMET03664 0.035 0.007 DBMET03665 | DBMET03664 | |
| 0.035 | 0.12 | 0.064 | Glucosylceramidase inhibitor | 0.052 0.043 DBMET00412 0.064 0.026 DBMET00498 | DBMET00498 | |
| 0.046 | 0.137 | 0.268 | Myeloperoxidase inhibitor | 0.268 0.004 DBMET03666 0.235 0.004 DB02377 0.115 0.022 DBMET00499 | DBMET03666 | |
| 0.037 | 0.128 | 0.163 | CDK2/cyclin E2 inhibitor | 0.163 0.015 DBMET03666 0.096 0.029 DB02377 | DBMET03666 | |
| 0.067 | 0.159 | 0.088 | Glutamate release inhibitor | 0.088 0.066 DBMET03666 | DBMET03666 | |
| 0.02 | 0.112 | 0.096 | CDK2/cyclin E inhibitor | 0.096 0.024 DBMET03666 | DBMET03666 | |
| 0.164 | 0.257 | 0.281 | Histamine release inhibitor | 0.255 0.152 DBMET03666 0.281 0.134 DB02377 0.28 0.135 DBMET00499 | DB02377 | |
| 0.121 | 0.221 | 0.41 | Cardiotonic | 0.41 0.027 DBMET00499 0.215 0.106 DB11100 | DBMET00499 | |
| 0.168 | 0.27 | 0.258 | Calcium channel activator | 0.258 0.137 DBMET03664 | DBMET03664 | |
| 0.022 | 0.126 | 0.062 | CDK4/cyclin D1 inhibitor | 0.062 0.037 DBMET03666 | DBMET03666 | |
| 0.026 | 0.131 | 0.217 | Cyclin A inhibitor | 0.217 0.008 DBMET03666 0.151 0.013 DB02377 0.055 0.048 DBMET00499 | DBMET03666 | |
| 0.052 | 0.169 | 0.363 | Cyclin-dependent kinase 2 inhibitor | 0.363 0.009 DBMET03666 0.265 0.015 DB02377 0.159 0.034 DBMET00499 | DBMET03666 | |
| 0.012 | 0.129 | 0.034 | Phosphodiesterase 6A inhibitor | 0.024 0.015 DB02377 0.034 0.005 DBMET00499 0.028 0.008 DBMET00498 | DBMET00499 | |
| 0.018 | 0.14 | 0.444 | Phosphatidylinositol 3-kinase delta inhibitor | 0.444 0.004 DBMET03666 0.144 0.012 DB02377 0.073 0.028 DBMET00499 | DBMET03666 | |
| 0.059 | 0.181 | 0.15 | Beta amyloid protein antagonist | 0.15 0.041 DBMET03666 | DBMET03666 | |
| 0.061 | 0.189 | 0.125 | Toll-Like receptor 4 antagonist | 0.125 0.038 DBMET03664 0.102 0.067 DBMET03665 | DBMET03664 | |
| 0.027 | 0.157 | 0.064 | Carbonic anhydrase VA inhibitor | 0.064 0.053 DBMET03664 | DBMET03664 | |
| 0.051 | 0.181 | 0.255 | Triose-phosphate isomerase inhibitor | 0.255 0.006 DBMET03664 0.124 0.03 DBMET03665 0.086 0.065 DB11100 | DBMET03664 | |
| 0.055 | 0.186 | 0.42 | Cyclin-dependent kinase inhibitor | 0.42 0.01 DBMET03666 0.269 0.024 DB02377 0.155 0.054 DBMET00499 | DBMET03666 | |
| 0.057 | 0.193 | 0.084 | MAP kinase 7 inhibitor | 0.084 0.031 DBMET03666 | DBMET03666 | |
| 0.053 | 0.196 | 0.288 | Lck kinase inhibitor | 0.288 0.018 DBMET03666 0.156 0.062 DB02377 0.103 0.099 DBMET00499 | DBMET03666 | |
| 0.067 | 0.212 | 0.115 | Interleukin 1 antagonist | 0.112 0.101 DBMET03666 0.115 0.096 DBMET00498 | DBMET00498 | |
| 0.055 | 0.205 | 0.193 | Epidermal growth factor receptor kinase inhibitor | 0.193 0.028 DBMET03666 0.113 0.08 DB02377 | DBMET03666 | |
| 0.024 | 0.175 | 0.052 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.052 0.051 DBMET03664 | DBMET03664 | |
| 0.023 | 0.177 | 0.299 | Phosphatidylinositol kinase inhibitor | 0.299 0.005 DBMET03666 | DBMET03666 | |
| 0.02 | 0.175 | 0.051 | CDK7/cyclin H inhibitor | 0.051 0.023 DBMET03666 | DBMET03666 | |
| 0.021 | 0.179 | 0.109 | Carbonic anhydrase V inhibitor | 0.109 0.024 DBMET03664 | DBMET03664 | |
| 0.018 | 0.178 | 0.06 | CDK4/cyclin D inhibitor | 0.06 0.038 DBMET03666 | DBMET03666 | |
| 0.051 | 0.214 | 0.431 | Ribosomal protein S6 kinase inhibitor | 0.232 0.026 DBMET03666 0.308 0.01 DB02377 0.431 0.005 DBMET00499 | DBMET00499 | |
| 0.028 | 0.194 | 0.145 | Antiviral (Hepatitis D) | 0.078 0.009 DBMET03664 0.145 0.003 DBMET03665 | DBMET03665 | |
| 0.024 | 0.191 | 0.241 | Phenylalanine 4-hydroxylase inhibitor | 0.112 0.021 DBMET03666 0.241 0.005 DB02377 0.082 0.036 DBMET00499 0.126 0.016 DBMET00498 | DB02377 | |
| 0.02 | 0.194 | 0.087 | mTOR inhibitor | 0.087 0.015 DBMET03666 0.05 0.038 DBMET00499 | DBMET03666 | |
| 0.033 | 0.21 | 0.11 | Epidermal growth factor antagonist | 0.11 0.038 DBMET03666 0.075 0.073 DB02377 | DBMET03666 | |
| 0.035 | 0.215 | 0.239 | Cyclin-dependent kinase 5 inhibitor | 0.239 0.016 DBMET03666 0.189 0.025 DB02377 0.124 0.055 DBMET00499 | DBMET03666 | |
| 0.01 | 0.193 | 0.113 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.113 0.014 DBMET03666 | DBMET03666 | |
| 0.081 | 0.268 | 0.17 | Platelet aggregation inhibitor | 0.17 0.107 DBMET00499 | DBMET00499 | |
| 0.042 | 0.231 | 0.131 | Anabolic | 0.107 0.054 DBMET03664 0.131 0.03 DBMET03665 | DBMET03665 | |
| 0.026 | 0.218 | 0.114 | MAP3K7 inhibitor | 0.114 0.016 DBMET03666 0.104 0.02 DB02377 | DBMET03666 | |
| 0.015 | 0.209 | 0.053 | HIV-1 integrase (Strand Transfer) inhibitor | 0.053 0.047 DBMET03664 | DBMET03664 | |
| 0.021 | 0.223 | 0.974 | Phosphodiesterase III inhibitor | 0.133 0.012 DBMET03666 0.238 0.005 DB02377 0.736 0.002 DBMET00499 0.974 0.001 DBMET00498 | DBMET00498 | |
| 0.018 | 0.222 | 0.057 | HIV-1 integrase (3'-Processing) inhibitor | 0.057 0.05 DBMET03664 | DBMET03664 | |
| 0.05 | 0.256 | 0.357 | Src kinase inhibitor | 0.357 0.017 DBMET03666 0.254 0.035 DB02377 0.181 0.064 DBMET00499 | DBMET03666 | |
| 0.01 | 0.218 | 0.069 | Phosphodiesterase 6B inhibitor | 0.045 0.009 DB02377 0.069 0.004 DBMET00499 0.069 0.004 DBMET00498 | DBMET00498 | |
| 0.027 | 0.238 | 0.134 | Phosphodiesterase 1B inhibitor | 0.076 0.025 DBMET03666 0.055 0.05 DB02377 0.134 0.008 DBMET00499 0.068 0.032 DBMET00498 | DBMET00499 | |
| 0.027 | 0.238 | 0.12 | Heat shock protein 90 beta antagonist | 0.12 0.007 DBMET03666 | DBMET03666 | |
| 0.005 | 0.217 | 0.041 | CDK2/cyclin A3 inhibitor | 0.041 0.002 DBMET03666 0.023 0.004 DB02377 | DBMET03666 | |
| 0.001 | 0.215 | 0.015 | Mannitol 2-dehydrogenase inhibitor | 0.015 0.003 DBMET03664 0.008 0.006 DBMET03665 | DBMET03664 | |
| 0.029 | 0.244 | 0.111 | Focal adhesion kinase 1 inhibitor | 0.111 0.023 DBMET03666 | DBMET03666 | |
| 0.149 | 0.372 | 0.266 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.207 0.147 DBMET00412 0.207 0.148 DBMET03666 0.259 0.055 DB02377 0.249 0.067 DBMET00499 0.266 0.048 DBMET00498 | DBMET00498 | |
| 0.02 | 0.243 | 0.088 | ErbB-4 antagonist | 0.088 0.047 DBMET03666 | DBMET03666 | |
| 0.007 | 0.23 | 0.04 | Geranyltranstransferase inhibitor | 0.04 0.036 DBMET03665 | DBMET03665 | |
| 0.027 | 0.252 | 0.117 | Phosphodiesterase 1A inhibitor | 0.089 0.013 DBMET03666 0.073 0.021 DB02377 0.117 0.007 DBMET00499 0.062 0.036 DB11100 | DBMET00499 | |
| 0.031 | 0.258 | 0.095 | Aminopeptidase B inhibitor | 0.095 0.069 DB11100 | DB11100 | |
| 0.033 | 0.261 | 0.194 | Glycogen synthase kinase-3 alpha inhibitor | 0.187 0.045 DBMET03666 0.149 0.068 DB02377 0.194 0.043 DBMET00499 | DBMET00499 | |
| 0.03 | 0.264 | 0.153 | Telomerase inhibitor | 0.063 0.061 DBMET03664 0.153 0.02 DB02377 0.074 0.049 DBMET03665 | DB02377 | |
| 0.022 | 0.257 | 0.151 | Platelet growth factor antagonist | 0.151 0.019 DBMET03666 | DBMET03666 | |
| 0.092 | 0.328 | 0.299 | Growth factor agonist | 0.178 0.089 DBMET03666 0.299 0.015 DB02377 | DB02377 | |
| 0.008 | 0.246 | 0.051 | Cyclin E inhibitor | 0.051 0.047 DBMET03666 | DBMET03666 | |
| 0.003 | 0.241 | 0.024 | Egl nine homolog 2 inhibitor | 0.024 0.004 DBMET00499 | DBMET00499 | |
| 0.155 | 0.396 | 0.37 | 5 Hydroxytryptamine release inhibitor | 0.37 0.099 DBMET03666 0.341 0.123 DB02377 0.243 0.238 DBMET00499 | DBMET03666 | |
| 0.033 | 0.274 | 0.509 | Bronchodilator | 0.31 0.009 DB02377 0.509 0.004 DBMET00499 | DBMET00499 | |
| 0.012 | 0.254 | 0.058 | Membrane dipeptidase inhibitor | 0.037 0.03 DBMET03664 0.058 0.011 DBMET03665 | DBMET03665 | |
| 0.044 | 0.286 | 0.165 | Interleukin 5 antagonist | 0.165 0.008 DBMET00498 | DBMET00498 | |
| 0.018 | 0.26 | 0.087 | Histidine decarboxylase inhibitor | 0.068 0.053 DBMET03666 0.087 0.038 DB02377 0.079 0.043 DBMET00499 0.074 0.047 DB11100 | DB02377 | |
| 0.012 | 0.256 | 0.079 | Dihydrofolate reductase inhibitor | 0.079 0.005 DBMET03666 0.072 0.006 DB02377 | DBMET03666 | |
| 0.018 | 0.265 | 0.237 | Phosphodiesterase V inhibitor | 0.078 0.043 DBMET03666 0.122 0.018 DB02377 0.237 0.005 DBMET00499 0.209 0.005 DBMET00498 | DBMET00499 | |
| 0.033 | 0.281 | 0.125 | EphA2 antagonist | 0.125 0.049 DBMET03666 | DBMET03666 | |
| 0.035 | 0.288 | 0.12 | Protein kinase C gamma inhibitor | 0.12 0.052 DB02377 | DB02377 | |
| 0.018 | 0.271 | 0.232 | Phosphodiesterase 5A inhibitor | 0.072 0.048 DBMET03666 0.098 0.028 DB02377 0.232 0.005 DBMET00499 0.211 0.005 DBMET00498 | DBMET00499 | |
| 0.013 | 0.269 | 0.097 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.097 0.016 DBMET03666 | DBMET03666 | |
| 0.006 | 0.262 | 0.031 | DNA polymerase III polC-type inhibitor | 0.017 0.004 DB02377 0.031 0.003 DBMET00499 | DBMET00499 | |
| 0.025 | 0.282 | 0.287 | Protein-tyrosine kinase Lyn inhibitor | 0.287 0.021 DBMET03666 0.171 0.057 DB02377 0.139 0.072 DBMET00499 | DBMET03666 | |
| 0.041 | 0.299 | 0.119 | Protein kinase C nu inhibitor | 0.109 0.107 DBMET03666 0.119 0.094 DBMET00499 | DBMET00499 | |
| 0.008 | 0.266 | 0.04 | Phosphodiesterase 6H inhibitor | 0.023 0.017 DB02377 0.031 0.007 DBMET00499 0.04 0.004 DBMET00498 | DBMET00498 | |
| 0.008 | 0.266 | 0.04 | Phosphodiesterase 6G inhibitor | 0.023 0.017 DB02377 0.031 0.007 DBMET00499 0.04 0.004 DBMET00498 | DBMET00498 | |
| 0.019 | 0.277 | 0.181 | Protein kinase (CK1) delta inhibitor | 0.119 0.074 DBMET03666 0.181 0.036 DB02377 | DB02377 | |
| 0.039 | 0.298 | 0.468 | Clk dual-specificity kinase inhibitor | 0.468 0.01 DBMET03666 0.157 0.108 DB02377 0.199 0.08 DBMET00499 | DBMET03666 | |
| 0.099 | 0.362 | 0.132 | Ca2+-transporting ATPase inhibitor | 0.13 0.122 DBMET00499 0.132 0.108 DBMET00498 | DBMET00498 | |
| 0.024 | 0.287 | 0.324 | c-Src kinase inhibitor | 0.324 0.014 DBMET03666 0.238 0.027 DB02377 0.195 0.037 DBMET00499 | DBMET03666 | |
| 0.025 | 0.289 | 0.067 | Polo-like kinase-2 inhibitor | 0.067 0.057 DBMET03664 | DBMET03664 | |
| 0.037 | 0.302 | 0.805 | Phosphodiesterase inhibitor | 0.12 0.082 DBMET03666 0.163 0.05 DB02377 0.625 0.004 DBMET00499 0.805 0.004 DBMET00498 | DBMET00498 | |
| 0.006 | 0.274 | 0.037 | Potassium channel small-conductance Ca-activated activator | 0.037 0.017 DBMET03666 0.036 0.018 DB02377 | DBMET03666 | |
| 0.05 | 0.319 | 0.301 | Diuretic | 0.151 0.077 DBMET03666 0.165 0.065 DB02377 0.301 0.022 DBMET00499 | DBMET00499 | |
| 0.035 | 0.306 | 0.194 | GABA receptor agonist | 0.194 0.019 DBMET03666 | DBMET03666 | |
| 0.108 | 0.38 | 0.244 | ErbB-1 antagonist | 0.244 0.055 DBMET03666 0.175 0.124 DB02377 | DBMET03666 | |
| 0.013 | 0.286 | 0.057 | EphB4 antagonist | 0.057 0.041 DBMET03666 0.052 0.047 DBMET00499 | DBMET03666 | |
| 0.062 | 0.335 | 0.142 | Interleukin 6 antagonist | 0.142 0.101 DB11100 | DB11100 | |
| 0.017 | 0.292 | 0.127 | Fibroblast growth factor 2 antagonist | 0.127 0.015 DBMET03666 0.063 0.048 DB02377 | DBMET03666 | |
| 0.021 | 0.296 | 0.177 | Fibroblast growth factor 1 antagonist | 0.177 0.023 DBMET03666 0.086 0.069 DB02377 | DBMET03666 | |
| 0.011 | 0.288 | 0.128 | Phosphodiesterase VII inhibitor | 0.091 0.017 DBMET03666 0.084 0.023 DB02377 0.128 0.005 DBMET00499 | DBMET00499 | |
| 0.014 | 0.293 | 0.198 | Syk tyrosine kinase inhibitor | 0.198 0.008 DBMET03666 0.087 0.035 DB02377 | DBMET03666 | |
| 0.05 | 0.328 | 0.322 | Heat shock protein 90 antagonist | 0.322 0.008 DBMET03666 | DBMET03666 | |
| 0.028 | 0.313 | 0.118 | Ephrin antagonist | 0.118 0.051 DBMET03666 0.105 0.059 DBMET00499 | DBMET03666 | |
| 0.029 | 0.313 | 0.131 | GABA A receptor agonist | 0.131 0.02 DBMET03666 | DBMET03666 | |
| 0.017 | 0.304 | 0.225 | Platelet activating factor beta antagonist | 0.225 0.02 DBMET03666 0.135 0.043 DB02377 0.085 0.075 DBMET00499 | DBMET03666 | |
| 0.039 | 0.331 | 0.094 | Granulocyte macrophage colony stimulating factor agonist | 0.094 0.044 DBMET03666 0.083 0.066 DB02377 | DBMET03666 | |
| 0.049 | 0.341 | 0.229 | Mannose-6-phosphate isomerase inhibitor | 0.229 0.018 DBMET03664 0.146 0.068 DBMET00498 | DBMET03664 | |
| 0.023 | 0.315 | 0.074 | Phosphodiesterase 6C inhibitor | 0.05 0.021 DB02377 0.064 0.006 DBMET00499 0.074 0.004 DBMET00498 | DBMET00498 | |
| 0.004 | 0.303 | 0.062 | Histamine H4 receptor agonist | 0.062 0.004 DBMET03666 0.058 0.004 DB02377 | DBMET03666 | |
| 0.012 | 0.312 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.008 DBMET03666 0.036 0.023 DB02377 0.034 0.032 DBMET00499 0.041 0.014 DBMET00498 | DBMET03666 | |
| 0.011 | 0.311 | 0.106 | Alcohol oxidase inhibitor | 0.057 0.038 DB02377 0.082 0.023 DBMET00499 0.053 0.042 DBMET00498 0.106 0.017 DB11100 | DB11100 | |
| 0.009 | 0.313 | 0.224 | Phosphodiesterase 4C inhibitor | 0.182 0.005 DB02377 0.144 0.008 DBMET00499 0.224 0.005 DBMET00498 0.117 0.011 DB11100 | DBMET00498 | |
| 0.063 | 0.371 | 0.275 | Tumour necrosis factor antagonist | 0.131 0.126 DBMET03666 0.231 0.037 DBMET00499 0.275 0.024 DB11100 | DB11100 | |
| 0.005 | 0.314 | 0.13 | Histamine H3 receptor agonist | 0.13 0.005 DBMET03666 0.115 0.005 DB02377 0.102 0.006 DBMET00499 | DBMET03666 | |
| 0.057 | 0.367 | 0.193 | Polo-like kinase-3 inhibitor | 0.125 0.117 DBMET03666 0.193 0.049 DBMET00499 | DBMET00499 | |
| 0.078 | 0.39 | 0.333 | Angiogenesis inhibitor | 0.289 0.098 DBMET03666 0.333 0.078 DB02377 | DB02377 | |
| 0.034 | 0.35 | 0.203 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.203 0.074 DBMET03666 | DBMET03666 | |
| 0.032 | 0.348 | 0.236 | Psychostimulant | 0.236 0.064 DBMET03664 0.162 0.106 DBMET03665 | DBMET03664 | |
| 0.016 | 0.338 | 0.159 | TIE-2 antagonist | 0.138 0.025 DBMET03666 0.159 0.02 DB02377 | DB02377 | |
| 0.028 | 0.354 | 0.317 | CDC-like kinase 2 inhibitor | 0.317 0.027 DBMET03666 | DBMET03666 | |
| 0.049 | 0.374 | 0.189 | Antimitotic | 0.189 0.09 DBMET03666 0.164 0.109 DBMET03664 | DBMET03666 | |
| 0.011 | 0.339 | 0.043 | MAP3K5 inhibitor | 0.042 0.023 DBMET03666 0.043 0.021 DB02377 | DB02377 | |
| 0.008 | 0.336 | 0.085 | Phosphodiesterase 4A inhibitor | 0.085 0.019 DB02377 0.085 0.019 DBMET00499 | DBMET00499 | |
| 0.015 | 0.347 | 0.159 | TIE antagonist | 0.138 0.026 DBMET03666 0.159 0.021 DB02377 | DB02377 | |
| 0.041 | 0.375 | 0.103 | Interleukin 8 antagonist | 0.103 0.09 DBMET00499 | DBMET00499 | |
| 0.009 | 0.349 | 0.15 | Phosphodiesterase 4D inhibitor | 0.15 0.019 DB02377 0.138 0.022 DBMET00499 0.094 0.04 DBMET00498 0.133 0.023 DB11100 | DB02377 | |
| 0.01 | 0.35 | 0.087 | Phosphatidylinositol 3-kinase beta inhibitor | 0.087 0.015 DBMET03666 | DBMET03666 | |
| 0.011 | 0.363 | 0.347 | Check point kinase 1 inhibitor | 0.062 0.056 DBMET03666 0.275 0.005 DB02377 0.347 0.005 DBMET00499 0.06 0.059 DBMET00498 0.121 0.02 DB11100 | DBMET00499 | |
| 0.013 | 0.368 | 0.066 | Cyclin-dependent kinase 4 inhibitor | 0.066 0.044 DBMET03666 | DBMET03666 | |
| 0.041 | 0.399 | 0.294 | Peroxidase inhibitor | 0.155 0.075 DBMET03666 0.258 0.046 DB02377 0.136 0.086 DBMET00499 0.142 0.082 DBMET00498 0.294 0.038 DB11100 | DB11100 | |
| 0.006 | 0.367 | 0.107 | CDK5/p25 inhibitor | 0.078 0.009 DBMET03666 0.107 0.005 DB02377 0.042 0.027 DBMET00499 | DB02377 | |
| 0.033 | 0.395 | 0.146 | Nav1.4 sodium channel blocker | 0.146 0.035 DB02377 | DB02377 | |
| 0.027 | 0.39 | 0.162 | MAP kinase kinase 1 inhibitor | 0.115 0.04 DBMET03666 0.162 0.012 DB02377 0.114 0.041 DBMET00499 0.103 0.053 DBMET00498 | DB02377 | |
| 0.012 | 0.379 | 0.119 | Leucine-rich repeat kinase 2 inhibitor | 0.119 0.032 DBMET03666 | DBMET03666 | |
| 0.039 | 0.411 | 0.108 | CDC-like kinase 3 inhibitor | 0.108 0.062 DBMET03666 | DBMET03666 | |
| 0.009 | 0.381 | 0.019 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.01 DB02377 | DB02377 | |
| 0.119 | 0.494 | 0.2 | MAP kinase kinase 3 inhibitor | 0.2 0.123 DB02377 | DB02377 | |
| 0.017 | 0.397 | 0.12 | Protein kinase B beta inhibitor | 0.092 0.031 DBMET03666 0.099 0.026 DB02377 0.12 0.015 DBMET00499 0.069 0.058 DBMET00498 | DBMET00499 | |
| 0.01 | 0.392 | 0.192 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.099 0.036 DBMET03666 0.156 0.012 DB02377 0.192 0.006 DBMET00499 | DBMET00499 | |
| 0.016 | 0.399 | 0.233 | Protein kinase (CK1) inhibitor | 0.165 0.056 DBMET03666 0.233 0.03 DB02377 0.149 0.068 DBMET00499 | DB02377 | |
| 0.023 | 0.407 | 0.314 | GABA C receptor agonist | 0.174 0.026 DBMET03666 0.314 0.009 DB02377 0.26 0.013 DBMET00499 0.257 0.013 DBMET00498 0.177 0.025 DB11100 | DB02377 | |
| 0.02 | 0.415 | 0.14 | TRKB antagonist | 0.14 0.054 DBMET03666 | DBMET03666 | |
| 0.021 | 0.417 | 0.284 | CDC-like kinase 4 inhibitor | 0.284 0.036 DBMET03666 0.18 0.079 DBMET00499 | DBMET03666 | |
| 0.027 | 0.429 | 0.524 | Pyruvate kinase inhibitor | 0.382 0.024 DBMET03664 0.524 0.007 DBMET03665 | DBMET03665 | |
| 0.019 | 0.422 | 0.175 | AXL receptor tyrosine kinase inhibitor | 0.175 0.012 DBMET03666 0.079 0.062 DB02377 | DBMET03666 | |
| 0.017 | 0.421 | 0.124 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.124 0.065 DB02377 | DB02377 | |
| 0.016 | 0.42 | 0.124 | Abl kinase inhibitor | 0.124 0.065 DB02377 | DB02377 | |
| 0.023 | 0.432 | 0.234 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.234 0.029 DBMET03666 | DBMET03666 | |
| 0.027 | 0.447 | 0.123 | Electrolyte absorption antagonist | 0.122 0.035 DBMET03666 0.119 0.037 DB02377 0.113 0.043 DBMET00499 0.123 0.034 DB11100 | DB11100 | |
| 0.001 | 0.42 | 0.019 | DNA topoisomerase III inhibitor | 0.009 0.004 DB02377 0.011 0.003 DBMET00499 0.019 0.002 DBMET00498 0.008 0.004 DB11100 | DBMET00498 | |
| 0.015 | 0.436 | 0.379 | Glycogen synthase kinase-3 inhibitor | 0.198 0.032 DBMET03666 0.379 0.01 DB02377 0.187 0.034 DBMET00499 | DB02377 | |
| 0.04 | 0.462 | 0.165 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.165 0.099 DBMET00499 | DBMET00499 | |
| 0.06 | 0.485 | 0.244 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.244 0.046 DBMET03666 0.195 0.078 DB02377 0.144 0.143 DBMET00499 | DBMET03666 | |
| 0.007 | 0.432 | 0.049 | Bruton tyrosine kinase inhibitor | 0.049 0.047 DB02377 | DB02377 | |
| 0.009 | 0.434 | 0.397 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.068 0.063 DBMET03666 0.357 0.005 DB02377 0.397 0.005 DBMET00499 0.121 0.027 DB11100 | DBMET00499 | |
| 0.008 | 0.433 | 0.164 | Histamine agonist | 0.164 0.004 DBMET03666 0.127 0.006 DB02377 0.05 0.039 DBMET00499 | DBMET03666 | |
| 0.023 | 0.451 | 0.156 | GABA C receptor rho-1 antagonist | 0.133 0.03 DBMET03666 0.147 0.023 DB02377 0.156 0.019 DBMET00499 0.091 0.076 DBMET00498 | DBMET00499 | |
| 0.02 | 0.455 | 0.313 | Anesthetic general | 0.135 0.131 DBMET00499 0.313 0.03 DB11100 | DB11100 | |
| 0.041 | 0.48 | 0.195 | GABA C receptor rho-2 antagonist | 0.168 0.053 DBMET03666 0.166 0.055 DB02377 0.195 0.032 DBMET00499 0.14 0.087 DBMET00498 | DBMET00499 | |
| 0.014 | 0.453 | 0.348 | Glycogen synthase kinase-3 beta inhibitor | 0.158 0.04 DBMET03666 0.348 0.01 DB02377 0.178 0.034 DBMET00499 | DB02377 | |
| 0.037 | 0.477 | 0.179 | Aurora-C kinase inhibitor | 0.179 0.027 DBMET03666 0.163 0.037 DB02377 | DBMET03666 | |
| 0.031 | 0.48 | 0.245 | Interleukin antagonist | 0.245 0.064 DBMET00498 | DBMET00498 | |
| 0.015 | 0.466 | 0.198 | MAP kinase kinase inhibitor | 0.17 0.041 DBMET03666 0.198 0.029 DB02377 0.166 0.043 DBMET00499 | DB02377 | |
| 0.008 | 0.469 | 0.047 | Bromodomain-containing protein 3 inhibitor | 0.047 0.039 DB11100 | DB11100 | |
| 0.029 | 0.49 | 0.174 | Heat shock protein 90 alpha antagonist | 0.174 0.066 DBMET03666 | DBMET03666 | |
| 0.009 | 0.472 | 0.097 | Platelet activating factor alpha antagonist | 0.097 0.062 DBMET03666 | DBMET03666 | |
| 0.02 | 0.483 | 0.089 | Phosphodiesterase 1C inhibitor | 0.066 0.035 DBMET03666 0.089 0.014 DBMET00499 0.082 0.018 DBMET00498 0.064 0.039 DB11100 | DBMET00499 | |
| 0.019 | 0.484 | 0.164 | Growth factor antagonist | 0.164 0.061 DBMET03666 0.11 0.103 DB02377 | DBMET03666 | |
| 0.022 | 0.488 | 0.262 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.262 0.044 DBMET00499 | DBMET00499 | |
| 0.004 | 0.475 | 0.037 | Protein kinase (CK1) epsilon inhibitor | 0.037 0.033 DBMET03666 | DBMET03666 | |
| 0.009 | 0.481 | 0.074 | Histamine H4 receptor antagonist | 0.074 0.01 DBMET03666 0.067 0.014 DB02377 | DBMET03666 | |
| 0.006 | 0.48 | 0.108 | Fibroblast growth factor 3 antagonist | 0.108 0.028 DBMET03666 | DBMET03666 | |
| 0.007 | 0.483 | 0.162 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.1 0.079 DBMET03666 0.162 0.048 DB02377 | DB02377 | |
| 0.004 | 0.481 | 0.031 | Glutaminyl-peptide cyclotransferase inhibitor | 0.021 0.017 DBMET03666 0.02 0.018 DB02377 0.031 0.006 DBMET00499 | DBMET00499 | |
| 0.005 | 0.485 | 0.046 | Glutamate (mGluR3) antagonist | 0.046 0.015 DBMET00498 | DBMET00498 | |
| 0.014 | 0.5 | 0.112 | Vascular endothelial growth factor 1 antagonist | 0.112 0.059 DBMET03666 | DBMET03666 | |
| 0.017 | 0.511 | 0.176 | Protein kinase (CK1) gamma 1 inhibitor | 0.176 0.052 DBMET03666 | DBMET03666 | |
| 0.012 | 0.508 | 0.135 | Platelet activating factor antagonist | 0.135 0.054 DBMET03666 | DBMET03666 | |
| 0.022 | 0.519 | 0.28 | Tyrosine kinase inhibitor | 0.28 0.047 DBMET03666 0.197 0.07 DB02377 | DBMET03666 | |
| 0.022 | 0.519 | 0.158 | Death-associated protein kinase 3 inhibitor | 0.158 0.11 DBMET03666 | DBMET03666 | |
| 0.014 | 0.517 | 0.107 | Tyrosine-protein kinase receptor antagonist | 0.107 0.1 DBMET03666 | DBMET03666 | |
| 0.015 | 0.519 | 0.128 | Cystathionine beta-synthase inhibitor | 0.128 0.052 DBMET00498 | DBMET00498 | |
| 0.005 | 0.51 | 0.165 | Somatostatin 4 antagonist | 0.165 0.004 DB11100 | DB11100 | |
| 0.043 | 0.551 | 0.235 | Transcription factor STAT inhibitor | 0.235 0.098 DBMET03664 | DBMET03664 | |
| 0.063 | 0.575 | 0.478 | GABA C receptor rho-3 antagonist | 0.392 0.065 DBMET03666 0.478 0.032 DB02377 0.454 0.04 DBMET00499 0.378 0.072 DBMET00498 0.274 0.134 DB11100 | DB02377 | |
| 0.009 | 0.522 | 0.286 | RET inhibitor | 0.286 0.025 DBMET03666 0.172 0.051 DB02377 0.28 0.026 DBMET00499 | DBMET03666 | |
| 0.018 | 0.534 | 0.38 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.38 0.009 DBMET00498 | DBMET00498 | |
| 0.009 | 0.527 | 0.158 | Granulocyte macrophage colony stimulating factor antagonist | 0.158 0.034 DBMET03666 0.097 0.075 DBMET00499 | DBMET03666 | |
| 0.029 | 0.548 | 0.161 | Succinate dehydrogenase inhibitor | 0.161 0.093 DBMET00498 | DBMET00498 | |
| 0.009 | 0.529 | 0.063 | Protein kinase B alpha inhibitor | 0.063 0.057 DB02377 | DB02377 | |
| 0.005 | 0.527 | 0.215 | Protein kinase (CK2) alpha inhibitor | 0.123 0.06 DBMET03666 0.215 0.022 DB02377 0.116 0.064 DBMET00499 | DB02377 | |
| 0.012 | 0.536 | 0.131 | Protein kinase (CK1) gamma 2 inhibitor | 0.131 0.058 DBMET03666 | DBMET03666 | |
| 0.019 | 0.543 | 0.275 | I kappa B kinase epsilon inhibitor | 0.275 0.025 DBMET03666 0.191 0.079 DB02377 | DBMET03666 | |
| 0.014 | 0.545 | 0.152 | GABA C receptor antagonist | 0.119 0.054 DBMET03666 0.144 0.033 DB02377 0.152 0.029 DBMET00499 0.124 0.049 DBMET00498 | DBMET00499 | |
| 0.023 | 0.553 | 0.476 | EphB2 antagonist | 0.301 0.035 DBMET03666 0.356 0.023 DB02377 0.476 0.009 DBMET00499 | DBMET00499 | |
| 0.011 | 0.544 | 0.096 | TRKA antagonist | 0.096 0.094 DBMET03666 | DBMET03666 | |
| 0.014 | 0.548 | 0.098 | Creatine kinase inhibitor | 0.098 0.062 DB02377 | DB02377 | |
| 0.006 | 0.545 | 0.097 | Histamine H2 receptor agonist | 0.082 0.007 DBMET03666 0.097 0.004 DB02377 0.058 0.016 DBMET00499 | DB02377 | |
| 0.017 | 0.556 | 0.333 | Somatostatin 1 agonist | 0.333 0.002 DB11100 | DB11100 | |
| 0.013 | 0.555 | 0.115 | M18 aspartyl aminopeptidase inhibitor | 0.115 0.075 DBMET00499 | DBMET00499 | |
| 0.005 | 0.557 | 0.077 | Janus tyrosine kinase 3 inhibitor | 0.077 0.047 DBMET03666 0.063 0.059 DB02377 | DBMET03666 | |
| 0.012 | 0.567 | 0.094 | Polo-like kinase-1 inhibitor | 0.094 0.055 DBMET03666 0.088 0.065 DBMET00499 | DBMET03666 | |
| 0.025 | 0.582 | 0.692 | Aldehyde oxidase inhibitor | 0.151 0.138 DBMET03666 0.294 0.068 DB02377 0.692 0.009 DBMET00499 0.178 0.118 DB11100 | DBMET00499 | |
| 0.005 | 0.565 | 0.082 | Nicotinic acid receptor agonist | 0.082 0.006 DBMET00499 | DBMET00499 | |
| 0.015 | 0.583 | 0.296 | MAP kinase 12 inhibitor | 0.118 0.072 DBMET03666 0.143 0.047 DB02377 0.296 0.007 DBMET00499 0.166 0.034 DBMET00498 | DBMET00499 | |
| 0.014 | 0.582 | 0.106 | MAP-kinase-activated kinase inhibitor | 0.106 0.034 DBMET00499 | DBMET00499 | |
| 0.021 | 0.589 | 0.144 | Cyclin-dependent kinase 8 inhibitor | 0.144 0.086 DBMET00499 | DBMET00499 | |
| 0.009 | 0.579 | 0.049 | Kainate receptor agonist | 0.039 0.035 DBMET00498 0.049 0.014 DB11100 | DB11100 | |
| 0.043 | 0.616 | 0.429 | Growth hormone agonist | 0.204 0.057 DBMET00499 0.429 0.012 DB11100 | DB11100 | |
| 0.01 | 0.584 | 0.032 | ATR kinase inhibitor | 0.032 0.026 DBMET03666 0.032 0.024 DB02377 | DB02377 | |
| 0.019 | 0.595 | 0.182 | Activin receptor-like kinase 2 inhibitor | 0.182 0.046 DBMET03666 0.123 0.093 DB02377 | DBMET03666 | |
| 0.006 | 0.583 | 0.072 | Porphobilinogen synthase inhibitor | 0.072 0.054 DBMET00499 | DBMET00499 | |
| 0.011 | 0.589 | 0.202 | Aryl hydrocarbon receptor agonist | 0.202 0.101 DBMET03666 | DBMET03666 | |
| 0.019 | 0.598 | 0.158 | HIV-1 integrase (Overall Integration) inhibitor | 0.158 0.022 DBMET00498 | DBMET00498 | |
| 0.009 | 0.588 | 0.139 | Protein kinase (CK1) gamma inhibitor | 0.139 0.074 DBMET03666 0.117 0.093 DBMET00499 | DBMET03666 | |
| 0.004 | 0.59 | 0.061 | Raf kinase C inhibitor | 0.061 0.041 DBMET03666 0.06 0.041 DB02377 | DBMET03666 | |
| 0.007 | 0.596 | 0.124 | CDC7 inhibitor | 0.124 0.014 DBMET03666 0.109 0.019 DB02377 0.069 0.045 DBMET00499 | DBMET03666 | |
| 0.016 | 0.614 | 0.06 | Carbonic anhydrase II stimulant | 0.06 0.023 DB02377 0.054 0.032 DBMET00499 | DB02377 | |
| 0.01 | 0.613 | 0.083 | MAP-kinase-activated kinase 2 inhibitor | 0.083 0.041 DBMET00499 | DBMET00499 | |
| 0.004 | 0.608 | 0.214 | Protein kinase (CK2) inhibitor | 0.106 0.058 DBMET03666 0.152 0.032 DB02377 0.214 0.016 DBMET00499 | DBMET00499 | |
| 0.01 | 0.616 | 0.128 | Vascular endothelial growth factor antagonist | 0.128 0.064 DBMET03666 0.098 0.084 DB02377 | DBMET03666 | |
| 0.007 | 0.614 | 0.117 | Vascular endothelial growth factor 2 antagonist | 0.117 0.062 DBMET03666 | DBMET03666 | |
| 0.024 | 0.636 | 0.15 | CDK3/cyclin E inhibitor | 0.15 0.027 DB02377 | DB02377 | |
| 0.006 | 0.622 | 0.09 | Insulin like growth factor 1 antagonist | 0.09 0.05 DBMET03666 | DBMET03666 | |
| 0.011 | 0.628 | 0.043 | CC chemokine 4 receptor antagonist | 0.043 0.04 DBMET00499 | DBMET00499 | |
| 0.006 | 0.626 | 0.093 | Insulin growth factor antagonist | 0.093 0.051 DBMET03666 | DBMET03666 | |
| 0.005 | 0.627 | 0.154 | MAP kinase kinase kinase inhibitor | 0.112 0.056 DBMET03666 0.154 0.033 DB02377 0.112 0.056 DBMET00499 | DB02377 | |
| 0.008 | 0.634 | 0.102 | Nitric-oxide synthase inhibitor | 0.102 0.057 DBMET03666 0.099 0.061 DB02377 | DBMET03666 | |
| 0.006 | 0.636 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.031 DB11100 | DB11100 | |
| 0.085 | 0.717 | 0.473 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.305 0.206 DBMET03666 0.433 0.074 DB02377 0.473 0.047 DBMET00499 0.344 0.158 DBMET00498 0.405 0.096 DB11100 | DBMET00499 | |
| 0.013 | 0.652 | 0.515 | Keratolytic | 0.515 0.002 DB11100 | DB11100 | |
| 0.006 | 0.646 | 0.033 | Carbonic anhydrase I stimulant | 0.033 0.032 DB02377 | DB02377 | |
| 0.001 | 0.643 | 0.031 | Egl nine homolog 3 inhibitor | 0.031 0.003 DBMET00499 0.025 0.004 DBMET00498 | DBMET00499 | |
| 0.016 | 0.659 | 0.094 | DOPA decarboxylase inhibitor | 0.094 0.089 DBMET00498 | DBMET00498 | |
| 0.005 | 0.654 | 0.083 | Glutamate decarboxylase inhibitor | 0.083 0.041 DB11100 | DB11100 | |
| 0.004 | 0.66 | 0.383 | Raf kinase inhibitor | 0.24 0.01 DBMET03666 0.227 0.01 DB02377 0.383 0.005 DBMET00499 | DBMET00499 | |
| 0.01 | 0.666 | 0.186 | Ferrochelatase inhibitor | 0.184 0.026 DB02377 0.159 0.034 DBMET00499 0.146 0.039 DBMET00498 0.186 0.026 DB11100 | DB11100 | |
| 0.007 | 0.666 | 0.096 | Carbonic anhydrase stimulant | 0.054 0.048 DBMET03666 0.096 0.02 DB02377 0.059 0.041 DBMET00499 | DB02377 | |
| 0.002 | 0.665 | 0.041 | Diamine oxidase inhibitor | 0.041 0.023 DB02377 | DB02377 | |
| 0.001 | 0.665 | 0.019 | Egl nine homolog 1 inhibitor | 0.018 0.006 DBMET00499 0.019 0.006 DBMET00498 | DBMET00498 | |
| 0.005 | 0.669 | 0.392 | Check point kinase 2 inhibitor | 0.103 0.062 DBMET03666 0.392 0.004 DB02377 0.089 0.075 DBMET00499 | DB02377 | |
| 0.004 | 0.673 | 0.408 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.275 0.01 DBMET03666 0.279 0.01 DB02377 0.408 0.005 DBMET00499 | DBMET00499 | |
| 0.01 | 0.68 | 0.202 | MAP kinase kinase 2 inhibitor | 0.202 0.08 DBMET03666 0.159 0.113 DB02377 0.158 0.114 DBMET00499 | DBMET03666 | |
| 0.059 | 0.732 | 0.31 | MAP kinase kinase 6 inhibitor | 0.31 0.126 DBMET00498 | DBMET00498 | |
| 0.005 | 0.68 | 0.174 | Aurora-B kinase inhibitor | 0.174 0.038 DBMET03666 | DBMET03666 | |
| 0.009 | 0.687 | 0.08 | GABA B receptor agonist | 0.08 0.042 DB02377 | DB02377 | |
| 0.004 | 0.687 | 0.191 | Phosphodiesterase IV inhibitor | 0.191 0.014 DBMET00499 0.117 0.034 DBMET00498 0.084 0.057 DB11100 | DBMET00499 | |
| 0.004 | 0.69 | 0.371 | Raf kinase B inhibitor | 0.175 0.011 DBMET03666 0.07 0.034 DB02377 0.371 0.005 DBMET00499 | DBMET00499 | |
| 0.004 | 0.691 | 0.042 | Stearoyl-CoA desaturase inhibitor | 0.042 0.033 DBMET00499 | DBMET00499 | |
| 0.008 | 0.698 | 0.034 | Transforming growth factor beta 2 antagonist | 0.034 0.021 DBMET00499 | DBMET00499 | |
| 0.005 | 0.698 | 0.06 | Somatostatin 1 antagonist | 0.06 0.015 DB11100 | DB11100 | |
| 0.006 | 0.704 | 0.221 | LIM domain kinase 1 inhibitor | 0.221 0.053 DBMET03666 0.188 0.069 DB02377 0.202 0.062 DBMET00499 | DBMET03666 | |
| 0.015 | 0.716 | 0.142 | Alpha 2d adrenoreceptor antagonist | 0.132 0.016 DBMET03666 0.13 0.017 DB02377 0.142 0.011 DBMET00499 | DBMET00499 | |
| 0.037 | 0.738 | 0.223 | MAP-kinase-activated kinase 5 inhibitor | 0.191 0.116 DB02377 0.223 0.08 DBMET00499 | DBMET00499 | |
| 0.003 | 0.707 | 0.075 | GABA receptor antagonist | 0.075 0.024 DBMET00498 | DBMET00498 | |
| 0.003 | 0.708 | 0.083 | Pim-3 kinase inhibitor | 0.083 0.071 DBMET00499 | DBMET00499 | |
| 0.003 | 0.708 | 0.076 | GABA A receptor antagonist | 0.076 0.023 DBMET00498 | DBMET00498 | |
| 0.007 | 0.713 | 0.138 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.138 0.072 DBMET00499 | DBMET00499 | |
| 0.007 | 0.721 | 0.151 | Polo-like kinase-4 inhibitor | 0.106 0.071 DB02377 0.151 0.035 DBMET00499 | DBMET00499 | |
| 0.013 | 0.728 | 0.08 | Exportin-1 inhibitor | 0.067 0.051 DB02377 0.08 0.025 DBMET00499 | DBMET00499 | |
| 0.002 | 0.719 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.015 DB02377 | DB02377 | |
| 0.01 | 0.739 | 0.233 | Focal adhesion kinase 2 inhibitor | 0.233 0.047 DBMET03666 | DBMET03666 | |
| 0.024 | 0.753 | 0.262 | Superoxide dismutase inhibitor | 0.195 0.123 DBMET00499 0.262 0.067 DB11100 | DB11100 | |
| 0.005 | 0.737 | 0.135 | Aurora-A kinase inhibitor | 0.135 0.047 DBMET03666 0.116 0.056 DB02377 | DBMET03666 | |
| 0.003 | 0.735 | 0.208 | Somatostatin 2 antagonist | 0.208 0.004 DB11100 | DB11100 | |
| 0.002 | 0.738 | 0.031 | Endothelial nitric-oxide synthase inhibitor | 0.031 0.021 DB02377 | DB02377 | |
| 0.003 | 0.743 | 0.035 | Alpha 2d adrenoreceptor agonist | 0.03 0.009 DB02377 0.035 0.007 DBMET00499 | DBMET00499 | |
| 0.004 | 0.747 | 0.059 | Protein kinase (CK2) beta inhibitor | 0.059 0.005 DBMET00499 0.031 0.028 DBMET00498 0.032 0.026 DB11100 | DBMET00499 | |
| 0.003 | 0.746 | 0.057 | Histamine H1 receptor agonist | 0.057 0.01 DB02377 0.053 0.015 DBMET00499 | DB02377 | |
| 0.006 | 0.753 | 0.055 | Glutamate (mGluR group III) antagonist | 0.055 0.016 DBMET00499 | DBMET00499 | |
| 0.002 | 0.752 | 0.057 | Alpha 1d adrenoreceptor agonist | 0.045 0.02 DB02377 0.057 0.012 DBMET00499 | DBMET00499 | |
| 0.007 | 0.761 | 0.248 | Alpha-glucosidase inhibitor | 0.248 0.188 DBMET00498 | DBMET00498 | |
| 0.001 | 0.755 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 DB02377 | DB02377 | |
| 0.04 | 0.799 | 0.215 | Tyrosine 3 hydroxylase inhibitor | 0.215 0.11 DBMET00498 0.189 0.157 DB11100 | DBMET00498 | |
| 0.006 | 0.771 | 0.057 | I kappa B kinase 2 inhibitor | 0.057 0.054 DB11100 | DB11100 | |
| 0.015 | 0.781 | 0.067 | Alpha 1b adrenoreceptor agonist | 0.066 0.014 DB02377 0.067 0.014 DBMET00499 | DBMET00499 | |
| 0.02 | 0.789 | 0.458 | MAP kinase 1 inhibitor | 0.25 0.233 DBMET00499 0.458 0.073 DBMET00498 | DBMET00498 | |
| 0.003 | 0.775 | 0.062 | Alpha 2 adrenoreceptor agonist | 0.062 0.04 DB02377 | DB02377 | |
| 0.002 | 0.775 | 0.058 | Dihydroorotate dehydrogenase inhibitor | 0.058 0.03 DBMET00499 | DBMET00499 | |
| 0.003 | 0.779 | 0.089 | Somatostatin 3 antagonist | 0.089 0.004 DB11100 | DB11100 | |
| 0.007 | 0.788 | 0.105 | Glutamate (mGluR4) antagonist | 0.049 0.022 DB02377 0.105 0.005 DBMET00499 | DBMET00499 | |
| 0.01 | 0.791 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 DBMET00498 | DBMET00498 | |
| 0.005 | 0.787 | 0.086 | Caspase 7 inhibitor | 0.086 0.049 DBMET00498 | DBMET00498 | |
| 0.006 | 0.795 | 0.081 | Phospholipase D inhibitor | 0.073 0.048 DBMET00499 0.081 0.033 DBMET00498 | DBMET00498 | |
| 0.002 | 0.8 | 0.026 | Acid ceramidase inhibitor | 0.026 0.017 DBMET00499 | DBMET00499 | |
| 0.008 | 0.827 | 0.351 | 15-Lipoxygenase inhibitor | 0.351 0.099 DBMET00498 | DBMET00498 | |
| 0.005 | 0.826 | 0.081 | Histamine H2 receptor antagonist | 0.079 0.067 DB02377 0.081 0.063 DB11100 | DB11100 | |
| 0.005 | 0.826 | 0.086 | Bromodomain-containing protein 2 inhibitor | 0.086 0.064 DBMET00499 0.08 0.076 DB11100 | DBMET00499 | |
| 0.008 | 0.845 | 0.178 | Thyroid hormone beta antagonist | 0.178 0.175 DBMET00498 | DBMET00498 | |
| 0.006 | 0.847 | 0.062 | Dihydroorotate oxidase inhibitor | 0.062 0.026 DBMET00499 0.061 0.027 DB11100 | DBMET00499 | |
| 0.013 | 0.854 | 0.205 | Insulysin inhibitor | 0.186 0.18 DBMET03666 0.19 0.173 DB02377 0.205 0.149 DBMET00499 | DBMET00499 | |
| 0.008 | 0.85 | 0.186 | Thyroid hormone antagonist | 0.186 0.174 DBMET00498 | DBMET00498 | |
| 0.004 | 0.849 | 0.421 | Prostaglandin dehydrogenase inhibitor | 0.421 0.061 DBMET00498 | DBMET00498 | |
| 0.005 | 0.851 | 0.12 | 5 Hydroxytryptamine 3A agonist | 0.12 0.055 DB11100 | DB11100 | |
| 0.044 | 0.893 | 0.227 | 5 Hydroxytryptamine 3E antagonist | 0.216 0.04 DB02377 0.227 0.03 DBMET00499 | DBMET00499 | |
| 0.001 | 0.851 | 0.032 | Nicotinic acid receptor 2 antagonist | 0.032 0.011 DBMET00499 | DBMET00499 | |
| 0.007 | 0.866 | 0.073 | Sirtuin 1 inhibitor | 0.073 0.041 DBMET00499 | DBMET00499 | |
| 0.001 | 0.862 | 0.126 | AMPA receptor antagonist | 0.059 0.025 DBMET00499 0.126 0.008 DBMET00498 | DBMET00498 | |
| 0.008 | 0.869 | 0.138 | Bone formation stimulant | 0.138 0.069 DBMET03664 | DBMET03664 | |
| 0.003 | 0.87 | 0.23 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.23 0.085 DBMET00498 | DBMET00498 | |
| 0.004 | 0.872 | 0.188 | Glutamate receptor antagonist | 0.188 0.03 DBMET00498 | DBMET00498 | |
| 0.001 | 0.873 | 0.073 | NMDA receptor glycine site agonist | 0.073 0.034 DB11100 | DB11100 | |
| 0.013 | 0.889 | 0.324 | Gastrin inhibitor | 0.324 0.019 DB11100 | DB11100 | |
| 0.004 | 0.881 | 0.033 | Somatostatin agonist | 0.033 0.021 DB11100 | DB11100 | |
| 0.003 | 0.88 | 0.063 | NMDA receptor agonist | 0.063 0.043 DB11100 | DB11100 | |
| 0.001 | 0.883 | 0.062 | NMDA receptor subunit 3B antagonist | 0.062 0.018 DBMET00498 | DBMET00498 | |
| 0.01 | 0.893 | 0.13 | Nav1.3 sodium channel blocker | 0.13 0.064 DBMET00499 | DBMET00499 | |
| 0.001 | 0.884 | 0.041 | NMDA receptor subunit 3A antagonist | 0.041 0.024 DBMET00498 | DBMET00498 | |
| 0.004 | 0.898 | 0.31 | DNA polymerase beta inhibitor | 0.31 0.16 DBMET00498 | DBMET00498 | |
| 0.005 | 0.91 | 0.31 | Streptokinase A inhibitor | 0.31 0.075 DBMET00498 | DBMET00498 | |
| 0.002 | 0.908 | 0.048 | Somatostatin 5 antagonist | 0.048 0.014 DB11100 | DB11100 | |
| 0.005 | 0.915 | 0.369 | Antiobesity | 0.369 0.078 DB11100 | DB11100 | |
| 0.015 | 0.929 | 0.191 | Heme oxygenase stimulant | 0.191 0.002 DBMET00498 | DBMET00498 | |
| 0.003 | 0.925 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.022 DBMET03664 0.033 0.028 DBMET03665 | DBMET03664 | |
| 0.027 | 0.949 | 0.158 | Sphingosine 1-phosphate receptor 2 agonist | 0.158 0.022 DBMET03664 | DBMET03664 | |
| 0.002 | 0.935 | 0.015 | Thyroid hormone alpha agonist | 0.015 0.014 DB11100 | DB11100 | |
| 0.002 | 0.935 | 0.086 | Calcitonin gene-related peptide antagonist | 0.086 0.003 DBMET00499 0.066 0.005 DBMET00498 0.073 0.004 DB11100 | DBMET00499 | |
| 0.002 | 0.945 | 0.027 | Kainate receptor 4 antagonist | 0.027 0.016 DBMET00498 | DBMET00498 | |
| 0.002 | 0.949 | 0.049 | Cholecystokinin agonist | 0.049 0.007 DB11100 | DB11100 | |
| 0.004 | 0.952 | 0.113 | M17 leucyl aminopeptidase inhibitor | 0.113 0.084 DBMET00498 | DBMET00498 | |
| 0.003 | 0.952 | 0.06 | Mineralocorticoid receptor antagonist | 0.06 0.02 DB11100 | DB11100 | |
| 0.001 | 0.951 | 0.137 | NMDA receptor antagonist | 0.137 0.029 DBMET00498 | DBMET00498 | |
| 0.001 | 0.969 | 0.118 | Calcitonin gene-related peptide 1 receptor antagonist | 0.118 0.003 DBMET00499 0.115 0.004 DBMET00498 0.114 0.004 DB11100 | DBMET00499 | |
| 0.004 | 0.971 | 0.314 | Potassium channel blocker | 0.314 0.042 DB11100 | DB11100 | |
| 0.002 | 0.971 | 0.066 | Sphingosine 1-phosphate receptor 3 agonist | 0.066 0.01 DBMET03664 | DBMET03664 | |
| 0.002 | 0.976 | 0.033 | Bradykinin antagonist | 0.033 0.032 DB11100 | DB11100 | |
| 0.003 | 0.982 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.041 DBMET03664 | DBMET03664 | |
| 0.002 | 0.985 | 0.08 | Nicotinic acid receptor 2 agonist | 0.08 0.008 DBMET00499 | DBMET00499 | |
| 0.003 | 0.986 | 0.367 | Thioredoxin glutathione reductase inhibitor | 0.367 0.07 DBMET00498 | DBMET00498 | |
| 0.001 | 0.991 | 0.925 | Cholecystokinin A antagonist | 0.925 0.001 DB11100 | DB11100 | |
| 0.002 | 0.992 | 0.054 | Kinesin-like protein 1 inhibitor | 0.054 0.015 DB11100 | DB11100 | |
| 0.002 | 0.992 | 0.054 | Kinesin antagonist | 0.054 0.015 DB11100 | DB11100 | |
| 0.001 | 0.993 | 0.909 | Cholecystokinin B antagonist | 0.909 0.001 DB11100 | DB11100 | |
| 0.001 | 0.995 | 0.946 | Cholecystokinin antagonist | 0.946 0.001 DB11100 | DB11100 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |